Prestige Consumer Healthcare (PBH) 10-Q 3 Aug 17 2018 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Jun. 30, 2017	Jul. 28, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Prestige Brands Holdings, Inc.
Entity Central Index Key	1,295,947
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		53,000,170

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Revenues
Net sales	$ 256,487	$ 208,770
Other revenues	86	805
Total revenues	256,573	209,575
Cost of Sales
Cost of sales excluding depreciation	111,757	87,984
Cost of sales depreciation	1,340	0
Cost of sales	113,097	87,984
Gross profit	143,476	121,591
Operating Expenses
Advertising and promotion	36,944	27,635
General and administrative	20,336	19,457
Depreciation and amortization	7,167	6,832
Loss on divestitures	0	55,453
Total operating expenses	64,447	109,377
Operating income	79,029	12,214
Other (income) expense
Interest income	(69)	(57)
Interest expense	26,410	21,184
Total other expense	26,341	21,127
Income before income taxes	52,688	(8,913)
Provision (benefit) for income taxes	18,929	(3,382)
Net income (loss)	$ 33,759	$ (5,531)
Earnings (loss) per share:
Basic (in USD per share)	$ 0.64	$ (0.10)
Diluted (in USD per share)	$ 0.63	$ (0.10)
Weighted average shares outstanding:
Basic (in shares)	53,038	52,881
Diluted (in shares)	53,509	52,881
Comprehensive income (loss), net of tax:
Currency translation adjustments	$ 1,119	$ (5,824)
Unrecognized net gain on pension plans	1	0
Total other comprehensive (loss) income	1,120	(5,824)
Comprehensive income (loss)	$ 34,879	$ (11,355)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017
Current assets
Cash and cash equivalents	$ 44,135	$ 41,855
Accounts receivable, net of allowance of $13,556 and $13,010, respectively	134,725	136,742
Inventories	118,707	115,609
Prepaid expenses and other current assets	30,658	40,228
Total current assets	328,225	334,434
Property, plant and equipment, net	50,469	50,595
Goodwill	615,451	615,252
Intangible assets, net	2,898,273	2,903,613
Other long-term assets	7,143	7,454
Total Assets	3,899,561	3,911,348
Current liabilities
Accounts payable	62,738	70,218
Accrued interest payable	8,414	8,130
Other accrued liabilities	82,465	83,661
Total current liabilities	153,617	162,009
Long-term debt
Principal amount	2,172,000	2,222,000
Less unamortized debt costs	(26,591)	(28,268)
Long-term debt, net	2,145,409	2,193,732
Deferred income tax liabilities	724,545	715,086
Other long-term liabilities	17,443	17,972
Total Liabilities	3,041,014	3,088,799
Commitments and Contingencies — Note 16
Stockholders' Equity
Preferred stock - $0.01 par value; Authorized - 5,000 shares; Issued and outstanding - None	0	0
Common stock - $0.01 par value; Authorized - 250,000 shares; Issued - 53,269 shares at June 30, 2017 and 53,287 shares at March 31, 2017	533	533
Additional paid-in capital	460,401	458,255
Treasury stock, at cost - 352 shares at June 30, 2017 and 332 shares at March 31, 2017	(7,621)	(6,594)
Accumulated other comprehensive loss, net of tax	(25,232)	(26,352)
Retained earnings	430,466	396,707
Total Stockholders' Equity	858,547	822,549
Total Liabilities and Stockholders' Equity	$ 3,899,561	$ 3,911,348

Condensed Consolidated Balance4

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable, current	$ 13,556	$ 13,010
Stockholders' Equity:
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	250,000,000	250,000,000
Common stock, shares issued (in shares)	53,352,000	53,287,000
Treasury stock, (in shares)	352,000	332,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Operating Activities
Net income (loss)	$ 33,759	$ (5,531)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	8,507	6,832
Loss on divestitures	0	55,453
Loss on disposals of property and equipment	490	0
Deferred income taxes	9,225	(9,660)
Amortization of debt origination costs	1,746	2,231
Excess tax benefits from share-based awards	302	550
Stock-based compensation costs	1,713	1,940
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	1,543	5,151
Inventories	(2,899)	(4,327)
Prepaid expenses and other current assets	9,604	5,697
Accounts payable	(8,024)	(3,401)
Accrued liabilities	(1,558)	(3,634)
Noncurrent assets and liabilities	(287)	0
Net cash provided by operating activities	54,121	51,301
Investing Activities
Purchases of property, plant and equipment	(2,554)	(895)
Acquisition of Fleet escrow payment	970	0
Net cash used in investing activities	(1,584)	(895)
Financing Activities
Term loan repayments	(50,000)	(50,000)
Payments of debt origination costs	0	(9)
Proceeds from exercise of stock options	433	3,405
Fair value of shares surrendered as payment of tax withholding	(1,027)	(1,395)
Net cash used in financing activities	(50,594)	(47,999)
Effects of exchange rate changes on cash and cash equivalents	337	(760)
Increase in cash and cash equivalents	2,280	1,647
Cash and cash equivalents - beginning of period	41,855	27,230
Cash and cash equivalents - end of period	44,135	28,877
Interest paid	24,298	18,337
Income taxes paid	$ 2,230	$ 1,357

Business and Basis of Presentat

Business and Basis of Presentation	3 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Basis of Presentation	Business and Basis of Presentation Nature of Business Prestige Brands Holdings, Inc. (referred to herein as the “Company” or “we,” which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Brands Holdings, Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (“OTC”) healthcare and household cleaning products to mass merchandisers and drug, food, dollar, convenience and club stores in North America (the United States and Canada) and in Australia and certain other international markets. Prestige Brands Holdings, Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 10 to these Condensed Consolidated Financial Statements. Basis of Presentation The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. All significant intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented. Our fiscal year ends on March 31 st of each year. References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., “2018”) mean our fiscal year ending or ended on March 31 st of that year. Operating results for the three months ended June 30, 2017 are not necessarily indicative of results that may be expected for the fiscal year ending March 31, 2018 . These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2017 . Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, the calculation of pension expense in our defined benefit plans, and the recognition of income taxes using an estimated annual effective tax rate. Reclassification In accordance with Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation (Topic 718) , we have reclassified cash flows on our Condensed Consolidated Statements of Cash Flows related to excess tax benefits from a financing activity to an operating activity for all periods presented. Revenue Recognition Revenues are recognized when the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the selling price is fixed or determinable, (iii) the product has been shipped and the customer takes ownership and assumes the risk of loss, and (iv) collection of the resulting receivable is reasonably assured. We have determined that these criteria are met and the transfer of the risk of loss generally occurs when the product is received by the customer, and, accordingly, we recognize revenue at that time. Provisions are made for estimated discounts related to customer payment terms and estimated product returns at the time of sale based on our historical experience. As is customary in the consumer products industry, we participate in the promotional programs of our customers to enhance the sale of our products. The cost of these promotional programs varies based on the actual number of units sold during a finite period of time. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. Estimates of the costs of these promotional programs are based on (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. We recognize the cost of such sales incentives by recording an estimate of such cost as a reduction of revenue, at the later of (a) the date the related revenue is recognized, or (b) the date when a particular sales incentive is offered. At the completion of a promotional program, the estimated amounts are adjusted to actual results. Due to the nature of the consumer products industry, we are required to estimate future product returns. Accordingly, we record an estimate of product returns concurrent with recording sales, which is made after analyzing (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. Cost of Sales Cost of sales includes product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs. Warehousing, shipping and handling and storage costs were $13.5 million for the three months ended June 30, 2017 , and $10.5 million for the three months ended June 30, 2016 . Advertising and Promotion Costs Advertising and promotion costs are expensed as incurred. Allowances for distribution costs associated with products, including slotting fees, are recognized as a reduction of sales. Under these slotting fee distribution arrangements, the retailers allow our products to be placed on the stores' shelves in exchange for such fees. Recently Issued Accounting Standards In May 2017, the Financial Accounting Standards Board ("FASB") issued ASU 2017-09, Compensation - Stock Compensation (Topic 718) . The amendments provide guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting under Topic 718. The amendments in this update are effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. We adopted ASU 2017-09 retrospectively effective April 1, 2017, and the adoption did not have a material impact on our Financial Statements. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350) . The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairments tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on our Financial Statements and whether to early adopt this ASU. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting this guidance on our Financial Statements. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments . The amendments in this update provide clarification and guidance on eight cash flow classification issues. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU 2016-15 is not expected to have a material impact on our Financial Statements. In February 2016, the FASB issued ASU 2016-02, Leases. The amendments in this update include a new FASB Accounting Standards Codification ("ASC") Topic 842, which supersedes Topic 840. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted for all entities as of the beginning of interim or annual reporting periods. We are evaluating the impact of adopting this guidance on our Financial Statements. In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory . The amendments in this update more closely align the measurement of inventory in GAAP with the measurement of inventory in International Financial Reporting Standards, under which an entity should measure inventory at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The adoption of ASU 2015-11, effective April 1, 2017, did not have a material impact on our Financial Statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers - Topic 606 , which supersedes the revenue recognition requirements in FASB ASC 605. The new guidance will eliminate industry-specific revenue recognition guidance under current GAAP and replace it with a principle-based approach for determining revenue recognition. This ASU primarily states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. This ASU will also require additional disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. In August 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU 2014-09 from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. With the issuance of ASU 2016-08 in March 2016, the FASB clarified the implementation guidance on principals versus agent considerations in FASB ASC 606. In April 2016, the FASB issued ASU 2016-10, which clarified implementation guidance on identifying performance obligations and licensing in FASB ASC 606. Certain narrow aspects of the guidance in FASB ASC 606 were amended with the issuances of ASU 2016-12 in May 2016 and ASU 2016-20 in December 2016. We expect to adopt this guidance when effective using the modified retrospective transition method. We have made substantial progress in completing our review of the impact of this guidance. Our implementation approach includes performing a detailed study of the various types of agreements that we have with our customers and assessing conformance of our current accounting practices with the new standard. We currently do not expect this new guidance to have a material impact on our financial statements, revenue recognition practices, or our internal controls. We continue to monitor additional amendments, clarifications and interpretations issued by the FASB that may affect our current conclusions.

Acquisitions

Acquisitions	3 Months Ended
	Jun. 30, 2017
Business Combinations [Abstract]
Acquisitions	Acquisitions Acquisition of Fleet On January 26, 2017, the Company completed the acquisition of C.B. Fleet Company, Inc. (" Fleet ") pursuant to the Agreement and Plan of Merger, dated as of December 22, 2016, for $823.7 million plus cash on hand at closing and subject to certain adjustments related to net working capital. The purchase price was funded by available cash on hand, additional borrowings under our asset-based revolving credit facility, and a new $740.0 million senior secured incremental term loan. As a result of the merger, we acquired multiple women's health, gastrointestinal and dermatological care OTC brands, including Summer’s Eve , Fleet , and Boudreaux's Butt Paste , as well as a “mix and fill” manufacturing facility in Lynchburg, Virginia. The financial results from the Fleet acquisition are included in the Company's North American and International OTC Healthcare segments. The acquisition was accounted for in accordance with Business Combinations topic of the FASB ASC 805, which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition. We prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition. The following table summarizes our allocation of the assets acquired and liabilities assumed as of the January 26, 2017 acquisition date. (In thousands) January 26, 2017 Cash $ 19,884 Accounts receivable 25,293 Inventories 20,812 Prepaid expenses and other current assets 17,024 Property, plant and equipment, net 38,661 Goodwill 268,577 Intangible assets, net 747,600 Other long-term assets 1,137 Total assets acquired 1,138,988 Accounts payable 10,412 Accrued expenses 22,895 Deferred income taxes - long term 261,555 Other long term liabilities 20,403 Total liabilities assumed 315,265 Total purchase price $ 823,723 Based on this preliminary analysis, we allocated $648.7 million to non-amortizable intangible assets and $98.9 million to amortizable intangible assets. We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 18.7 years . We recorded goodwill of $268.6 million based on the amount by which the purchase price exceeded the fair value of the net assets acquired. Goodwill is not deductible for income tax purposes. The following table provides our unaudited pro forma revenues, net income and net income per basic and diluted common share had the results of Fleet's operations been included in our operations commencing on April 1, 2016, based on available information related to Fleet's operations. This pro forma information is not necessarily indicative either of the combined results of operations that actually would have been realized by us had the Fleet acquisition been consummated at the beginning of the period for which the pro forma information is presented, or of future results. Three Months Ended June 30, 2016 (In thousands, except per share data) (Unaudited) Revenues $ 260,776 Net income $ (5,930 ) Earnings per share: Basic EPS $ (0.11 ) Diluted EPS $ (0.11 )

Divestitures

Divestitures	3 Months Ended
	Jun. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]
Divestitures	Divestitures Divestitures Late in the first quarter of fiscal 2017, the Company was approached and discussed the potential to sell certain businesses. Prior to these discussions, the Company did not contemplate any divestitures, and the Company did not commit to any course of action to divest any of the businesses until entering into an agreement on June 29, 2016 to sell Pediacare, New Skin and Fiber Choice , which were reported under the North American OTC Healthcare segment in the Cough & Cold, Dermatologicals and Gastrointestinal product groups, respectively. This transaction met the criteria as held for sale, and the related assets were measured at the lower of the carrying value or fair value less any costs to sell based on the agreed-upon sales price. As a result, in the first quarter of fiscal 2017 , we recorded the held for sale assets at their estimated fair value and recorded a pre-tax loss on sale of $55.5 million .

Inventories

Inventories	3 Months Ended
	Jun. 30, 2017
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consist of the following: (In thousands) June 30, March 31, Components of Inventories, net Packaging and raw materials $ 12,887 $ 9,984 Work in process 366 369 Finished goods 105,454 105,256 Inventories $ 118,707 $ 115,609 Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $4.9 million and $6.6 million at June 30, 2017 and March 31, 2017 , respectively, related to obsolete and slow-moving inventory.

Goodwill

Goodwill	3 Months Ended
	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill A reconciliation of the activity affecting goodwill by operating segment is as follows: (In thousands) North American OTC Healthcare International OTC Healthcare Household Cleaning Consolidated Balance — March 31, 2017 $ 576,453 $ 32,554 $ 6,245 $ 615,252 Adjustments — — — — Effects of foreign currency exchange rates — 199 — 199 Balance — June 30, 2017 $ 576,453 $ 32,753 $ 6,245 $ 615,451 As discussed in Note 2, on January 26, 2017, we completed the acquisition of Fleet . In connection with this acquisition, we recorded goodwill of $268.6 million based on the amount by which the purchase price exceeded the fair value of the net assets acquired. Under accounting guidelines, goodwill is not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below the carrying amount. On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment. At February 28, 2017 , during our annual test for goodwill impairment, there were no indicators of impairment under the analysis. Accordingly, no impairment charge was recorded in fiscal 2017 . We utilize the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test. We also considered our market capitalization at February 28, 2017 , which was the date of our annual review, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology. The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties. Consequently, changing rates of interest and inflation, declining sales or margins, increases in competition, changing consumer preferences, technical advances, or reductions in advertising and promotion may require an impairment charge to be recorded in the future. As of June 30, 2017 , no events have occurred that would indicate potential impairment of goodwill.

Intangible Assets, net

Intangible Assets, net	3 Months Ended
	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets, net A reconciliation of the activity affecting intangible assets, net is as follows: (In thousands) Indefinite Lived Trademarks Finite Lived Totals Gross Carrying Amounts Balance — March 31, 2017 $ 2,589,155 $ 441,801 $ 3,030,956 Effects of foreign currency exchange rates 460 60 520 Balance — June 30, 2017 2,589,615 441,861 3,031,476 Accumulated Amortization Balance — March 31, 2017 — 127,343 127,343 Additions — 5,854 5,854 Effects of foreign currency exchange rates — 6 6 Balance — June 30, 2017 — 133,203 133,203 Intangible assets, net - June 30, 2017 $ 2,589,615 $ 308,658 $ 2,898,273 As discussed in Note 2, on January 26, 2017, we completed the acquisition of Fleet . In connection with this acquisition, we allocated $747.6 million to intangible assets based on our analysis. Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount. Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life. Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value. On an annual basis during the fourth fiscal quarter, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of both the values and, if applicable, useful lives assigned to intangible assets and tests for impairment. We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets. We also considered our market capitalization at February 28, 2017 , which was the date of our annual impairment review. The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties. Consequently, changing rates of interest and inflation, declining sales or margins, increases in competition, changing consumer preferences, technical advances, or reductions in advertising and promotion may require an impairment charge to be recorded in the future.

Other Accrued Liabilities

Other Accrued Liabilities	3 Months Ended
	Jun. 30, 2017
Payables and Accruals [Abstract]
Other Accrued Liabilities	Other Accrued Liabilities Other accrued liabilities consist of the following: (In thousands) June 30, March 31, Accrued marketing costs $ 35,284 $ 29,384 Accrued compensation costs 8,973 15,535 Accrued broker commissions 1,096 1,782 Income taxes payable 38 3,840 Accrued professional fees 2,168 2,412 Deferred rent 482 492 Accrued production costs 6,883 4,580 Accrued lease termination costs 730 843 Income tax related payable 19,000 19,000 Other accrued liabilities 7,811 5,793 $ 82,465 $ 83,661

Long-Term Debt

Long-Term Debt	3 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt At June 30, 2017 , we had $90.0 million outstanding on the asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and a borrowing capacity of $77.4 million . Long-term debt consists of the following, as of the dates indicated: (In thousands, except percentages) June 30, March 31, 2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year. The 2016 Senior Notes mature on March 1, 2024. $ 350,000 $ 350,000 2013 Senior Notes bearing interest at 5.375%, with interest payable on June 15 and December 15 of each year. The 2013 Senior Notes mature on December 15, 2021. 400,000 400,000 2012 Term B-4 Loans bearing interest at our option at either LIBOR plus a margin of 2.75%, with a LIBOR floor of 0.75%, or a base rate plus a margin (with a margin step-down to 2.50%) due on January 26, 2024. 1,332,000 1,382,000 2012 ABL Revolver bearing interest at our option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on January 26, 2022. 90,000 90,000 Total long-term debt (including current portion) 2,172,000 2,222,000 Current portion of long-term debt — — Long-term debt 2,172,000 2,222,000 Less: unamortized debt costs (26,591 ) (28,268 ) Long-term debt, net $ 2,145,409 $ 2,193,732 As of June 30, 2017 , aggregate future principal payments required in accordance with the terms of the 2012 Term B-4 Loans, 2012 ABL Revolver and the indentures governing the 6.375% senior unsecured notes due 2024 (the "2016 Senior Notes") and the 5.375% senior unsecured notes due 2021 (the "2013 Senior Notes") are as follows: (In thousands) Year Ending March 31, Amount 2018 (remaining nine months ending March 31, 2018) $ — 2019 — 2020 — 2021 — 2022 490,000 Thereafter 1,682,000 $ 2,172,000

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts. The Fair Value Measurements and Disclosures topic of the FASB ASC 820 requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants. The Fair Value Measurements and Disclosures topic established market (observable inputs) as the preferred source of fair value, to be followed by the Company's assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs. Based upon the above, the following fair value hierarchy was created: Level 1 - Quoted market prices for identical instruments in active markets; Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and Level 3 - Unobservable inputs developed by the Company using estimates and assumptions reflective of those that would be utilized by a market participant. The market values have been determined based on market values for similar instruments adjusted for certain factors. As such, the 2016 Senior Notes, the 2013 Senior Notes, the 2012 Term B-4 Loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these borrowings at June 30, 2017 and March 31, 2017 ). June 30, 2017 March 31, 2017 (In thousands) Carrying Value Fair Value Carrying Value Fair Value 2016 Senior Notes $ 350,000 $ 373,188 $ 350,000 $ 367,500 2013 Senior Notes 400,000 412,500 400,000 409,000 2012 Term B-4 Loans 1,332,000 1,336,995 1,382,000 1,395,820 2012 ABL Revolver 90,000 90,000 90,000 90,000 At June 30, 2017 and March 31, 2017 , we did not have any assets or liabilities measured in Level 1 or 3. In accordance with ASU 2015-07, investments that are measured at fair value using net asset value ("NAV") per share as a practical expedient have not been classified in the fair value hierarchy.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Jun. 30, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders' Equity The Company is authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share. The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof. Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends. No dividends have been declared or paid on the Company's common stock through June 30, 2017 . During the three months ended June 30, 2017 and 2016 , we repurchased 19,616 shares and 24,988 shares, respectively, of restricted common stock from our employees pursuant to the provisions of various employee restricted stock awards. The repurchases for the three months ended June 30, 2017 and 2016 were at an average price of $52.36 and $55.82 , respectively. All of the repurchased shares have been recorded as treasury stock.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Jun. 30, 2017
Stockholders' Equity Note [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The table below presents accumulated other comprehensive loss (“AOCI”), which affects equity and results from recognized transactions and other economic events, other than transactions with owners in their capacity as owners. AOCI consisted of the following at June 30, 2017 and March 31, 2017 : June 30, March 31, (In thousands) 2017 2017 Components of Accumulated Other Comprehensive Loss Cumulative translation adjustment $ (24,981 ) $ (26,100 ) Unrecognized net loss on pension plans (251 ) (252 ) Accumulated other comprehensive loss, net of tax $ (25,232 ) $ (26,352 ) As of June 30, 2017 and March 31, 2017 , no amounts were reclassified from accumulated other comprehensive income into earnings.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Jun. 30, 2017
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed based on the weighted-average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units. In loss periods, the assumed exercise of in-the-money stock options and restricted stock units has an anti-dilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share. The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended June 30, (In thousands, except per share data) 2017 2016 Numerator Net income (loss) $ 33,759 $ (5,531 ) Denominator Denominator for basic earnings per share — weighted average shares outstanding 53,038 52,881 Dilutive effect of unvested restricted stock units and options issued to employees and directors 471 — Denominator for diluted earnings per share 53,509 52,881 Earnings per Common Share: Basic net earnings (loss) per share $ 0.64 $ (0.10 ) Diluted net earnings (loss) per share $ 0.63 $ (0.10 ) For the three months ended June 30, 2017 and 2016 , there were 0.4 million and 0.7 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation	Share-Based Compensation In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the “Plan”), which provides for grants of up to a maximum of 5.0 million shares of restricted stock, stock options, restricted stock units ("RSUs") and other equity-based awards. In June 2014, the Board of Directors approved, and in July 2014, the stockholders ratified, an increase of an additional 1.8 million shares of our common stock for issuance under the Plan, increased the maximum number of shares subject to stock options that may be awarded to any one participant under the Plan during any fiscal 12-month period from 1.0 million to 2.5 million shares, and extended the term of the Plan by ten years, to February 2025. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, are eligible for grants under the Plan. During the three months ended June 30, 2017 and 2016 , pre-tax share-based compensation costs charged against income were $1.7 million and $1.9 million , respectively, and the related income tax benefit recognized was $0.5 million and $0.7 million , respectively. At June 30, 2017 , there were $12.8 million of unrecognized compensation costs related to unvested share-based compensation arrangements under the Plan, based on management's estimate of the shares that will ultimately vest. We expect to recognize such costs over a weighted-average period of 1.0 year. The total fair value of options and restricted stock units vested during the three months ended June 30, 2017 and 2016 was $4.9 million and $7.0 million , respectively. For the three months ended June 30, 2017 and 2016 , we received cash from the exercise of stock options of $0.4 million and $3.4 million . For the three months ended June 30, 2017 and 2016, we realized $0.9 million and $1.4 million , respectively, in tax benefits from the tax deductions resulting from restricted stock issuances and stock option exercises. At June 30, 2017 , there were 2.2 million shares available for issuance under the Plan. On May 8, 2017, the Compensation Committee of our Board of Directors granted 35,593 performance units, 54,773 RSUs and stock options to acquire 182,823 shares of our common stock to certain executive officers and employees under the Plan. The stock options were granted at an exercise price of $56.11 per share, which is equal to the closing price for our common stock on the date of the grant. Restricted Stock Units RSUs granted to employees under the Plan generally vest in three to five years, primarily upon the attainment of certain time vesting thresholds, and, in the case of performance share units, may also be contingent on the attainment of certain performance goals of the Company, including revenue and earnings before income taxes, depreciation and amortization targets. The RSUs provide for accelerated vesting if there is a change of control, as defined in the Plan. The RSUs granted to employees generally vest either ratably over three years or in their entirety on the three -year anniversary of the date of the grant. Upon vesting, the units will be settled in shares of our common stock. Termination of employment prior to vesting will result in forfeiture of the RSUs, unless otherwise accelerated by the Compensation and Talent Management Committee or, in the case of RSUs granted in May 2017, subject to pro-rata vesting in the event of death, disability or retirement. The RSUs granted to directors vest in their entirety one year after the date of grant so long as membership on the Board of Directors continues through the vesting date, and will be settled by delivery to the director of one share of common stock of the Company for each vested RSU promptly following the earliest of the director's (i) death, (ii) disability or (iii) the six -month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability. The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. The weighted-average grant-date fair value of RSUs granted during the three months ended June 30, 2017 and 2016 was $56.11 and $57.16 , respectively. A summary of the Company's RSUs granted under the Plan is presented below: RSUs Shares (in thousands) Weighted- Average Grant-Date Fair Value Three months ended June 30, 2016 Vested and nonvested at March 31, 2016 467.8 $ 35.22 Granted 49.4 57.16 Vested and issued (75.6 ) 31.36 Forfeited (76.2 ) 39.93 Vested and nonvested at June 30, 2016 365.4 38.00 Vested at June 30, 2016 70.2 14.89 Three months ended June 30, 2017 Vested and nonvested at March 31, 2017 350.1 $ 39.29 Granted 90.4 56.11 Vested and issued (50.8 ) 34.28 Forfeited (2.3 ) 50.06 Vested and nonvested at June 30, 2017 387.4 43.81 Vested at June 30, 2017 63.7 20.31 Options The Plan provides that the exercise price of options granted shall be no less than the fair market value of the Company's common stock on the date the options are granted. Options granted have a term of no greater than ten years from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally three to five years. The option awards provide for accelerated vesting in the event of a change in control, as defined in the Plan. Except in the case of death, disability or retirement, termination of employment prior to vesting will result in forfeiture of the unvested stock options. Vested stock options will remain exercisable by the employee after termination of employment, subject to the terms in the Plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions noted in the table below. Expected volatilities are based on the historical volatility of our common stock and other factors, including the historical volatilities of comparable companies. We use appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors. Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation. The expected terms of the options granted are derived from our historical experience, management's estimates, and consideration of information derived from the public filings of companies similar to us, and represent the period of time that options granted are expected to be outstanding. The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted options. The weighted-average grant-date fair values of the options granted during the three months ended June 30, 2017 and 2016 were $21.20 and $22.26 , respectively. Three months ended June 30, 2017 2016 Expected volatility 35.2 % 37.8 % Expected dividends $ — $ — Expected term in years 6.0 6.0 Risk-free rate 2.2 % 1.7 % A summary of option activity under the Plan is as follows: Options Shares (in thousands) Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Three months ended June 30, 2016 Outstanding at March 31, 2016 727.7 $ 30.70 Granted 224.8 57.18 Exercised (105.7 ) 32.20 Forfeited or expired (45.5 ) 37.34 Outstanding at June 30, 2016 801.3 37.55 8.0 $ 14,700 Exercisable at June 30, 2016 386.4 25.20 6.7 $ 11,669 Three months ended June 30, 2017 Outstanding at March 31, 2017 772.3 $ 37.70 Granted 182.8 56.11 Exercised (13.8 ) 31.35 Forfeited or expired (5.8 ) 32.64 Outstanding at June 30, 2017 935.5 41.42 7.7 $ 12,123 Exercisable at June 30, 2017 527.3 31.95 6.5 $ 11,305 The aggregate intrinsic value of options exercised in the three months ended June 30, 2017 was $0.3 million .

Income Taxes

Income Taxes	3 Months Ended
	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur. The effective rates used in the calculation of income taxes were 35.9% and 37.9% for the three months ended June 30, 2017 and 2016 , respectively. The decrease in the effective tax rate for the three months ended June 30, 2017 was primarily due to tax adjustments on the sale of New Skin in the prior year. The balance in our uncertain tax liability was $3.7 million at June 30, 2017 and March 31, 2017 . We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. We did not incur any material interest or penalties related to income taxes in any of the periods presented.

Employee Retirement Plans

Employee Retirement Plans	3 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Employee Retirement Plans	Employee Retirement Plans The primary components of Net Periodic Benefits consist of the following: Period Ended (In thousands) June 30, 2017 Interest cost $ 629 Expected return on assets (726 ) Net periodic benefit cost (income) $ (97 ) We had a net periodic benefit of $0.1 million for the three months ended June 30, 2017 . During the quarter, the Company contributed $0.1 million to the non-qualified defined benefit plan and made no contributions to the qualified defined benefit plan. During the remainder of fiscal 2018 , we expect to contribute $0.3 million to the non-qualified plan and make no contributions to the qualified plan. The determination of the expected long-term rate of return was derived from an optimized portfolio using an asset allocation software program. The risk and return assumptions, along with the correlations between the asset classes, were entered into the program. Based on these assumptions and historical experience, the portfolio is expected to achieve a long-term rate of return of 6.25% . The investment managers engaged to manage the portfolio are expected to outperform their expected benchmarks on a relative basis over a full market cycle.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies We are involved from time to time in legal matters and other claims incidental to our business. We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss. These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted. The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve. In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement). We believe the resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations. Purchase Commitments We have supply agreements for the manufacture of some of our products. The following table shows the minimum amounts that we are committed to pay under these agreements: (In thousands) Year Ending March 31, Amount 2018 (Remaining nine months ending March 31, 2018) 4,257 2019 9,082 2020 9,859 2021 9,300 2022 9,300 Thereafter 2,300 $ 44,098

Concentrations of Risk

Concentrations of Risk	3 Months Ended
	Jun. 30, 2017
Risks and Uncertainties [Abstract]
Concentrations of Risk	Concentrations of Risk Our revenues are concentrated in the areas of OTC Healthcare and Household Cleaning products. We sell our products to mass merchandisers and drug, food, dollar, convenience and club stores. During the three months ended June 30, 2017 and 2016 , approximately 43.2% and 42.3% , respectively, of our total revenues were derived from our five top selling brands. Two customers, Walmart and Walgreens, accounted for more than 10% of our gross revenues for each of the periods presented. Walmart accounted for approximately 25.5% and 20.7% of our gross revenues for the three months ended June 30, 2017 and 2016 , respectively. Walgreens accounted for approximately 9.1% and 10.3% of gross revenues for the three months ended June 30, 2017 and 2016 , respectively. At June 30, 2017 , approximately 26.1% and 7.9% of accounts receivable were owed by Walmart and Walgreens, respectively. We manage product distribution in the continental United States through a third-party distribution center in St. Louis, Missouri. A serious disruption, such as an earthquake, flood or fire, to the main distribution center could damage our inventories and could materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost. We could incur significantly higher costs and experience longer lead times associated with the distribution of our products to our customers during the time that it takes us to reopen or replace our distribution center. As a result, any such disruption could have a material adverse effect on our business, sales and profitability. At June 30, 2017 , we had relationships with 116 third-party manufacturers. Of those, we had long-term contracts with 48 manufacturers that produced items that accounted for approximately 77.2% of gross sales for the three months ended June 30, 2017 . At June 30, 2016 , we had relationships with 102 third-party manufacturers. Of those, we had long-term contracts with 55 manufacturers that produced items that accounted for approximately 79.7% of gross sales for the nine months ended June 30, 2016 . The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations. Although we are in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.

Business Segments

Business Segments	3 Months Ended
	Jun. 30, 2017
Segment Reporting [Abstract]
Business Segments	Business Segments Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280. Our current reportable segments consist of (i) North American OTC Healthcare, (ii) International OTC Healthcare and (iii) Household Cleaning. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and promotional expenses. The tables below summarize information about our reportable segments. Three Months Ended June 30, 2017 (In thousands) North American OTC International OTC Household Cleaning Consolidated Total segment revenues* $ 215,815 $ 20,898 $ 19,860 $ 256,573 Cost of sales 86,501 9,950 16,646 113,097 Gross profit 129,314 10,948 3,214 143,476 Advertising and promotion 32,808 3,690 446 36,944 Contribution margin $ 96,506 $ 7,258 $ 2,768 106,532 Other operating expenses 27,503 Operating income 79,029 Other expense 26,341 Income before income taxes 52,688 Provision for income taxes 18,929 Net income $ 33,759 * Intersegment revenues of $1.4 million were eliminated from the North American OTC Healthcare segment. Three Months Ended June 30, 2016 (In thousands) North American OTC International OTC Household Cleaning Consolidated Total segment revenues* $ 172,080 $ 15,804 $ 21,691 $ 209,575 Cost of sales** 64,234 6,948 16,802 87,984 Gross profit 107,846 8,856 4,889 121,591 Advertising and promotion 25,040 2,124 471 27,635 Contribution margin $ 82,806 $ 6,732 $ 4,418 93,956 Other operating expenses*** 81,742 Operating income 12,214 Other expense 21,127 Loss before income taxes (8,913 ) Benefit for income taxes (3,382 ) Net loss $ (5,531 ) * Intersegment revenues of $1.2 million were eliminated from the North American OTC Healthcare segment. **Certain immaterial amounts related to cost of sales were reclassified between the International OTC Healthcare segment and the North American OTC Healthcare segment. There were no changes to the condensed consolidated financial statements for any periods presented. ***Other operating expenses includes a pre-tax loss on sale of assets of $55.5 million recognized for assets held for sale related to Pediacare , New Skin and Fiber Choice . These assets and corresponding contribution margin are included within the North American OTC Healthcare segment. The tables below summarize information about our segment revenues from similar product groups. Three Months Ended June 30, 2017 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 29,290 $ 509 $ — $ 29,799 Cough & Cold 17,410 4,613 — 22,023 Women's Health 63,145 3,594 — 66,739 Gastrointestinal 30,430 5,733 — 36,163 Eye & Ear Care 25,271 3,055 — 28,326 Dermatologicals 24,131 501 — 24,632 Oral Care 24,892 2,892 — 27,784 Other OTC 1,246 1 — 1,247 Household Cleaning — — 19,860 19,860 Total segment revenues $ 215,815 $ 20,898 $ 19,860 $ 256,573 Three Months Ended June 30, 2016 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 28,126 $ 527 $ — $ 28,653 Cough & Cold 17,967 4,392 — 22,359 Women's Health 32,887 936 — 33,823 Gastrointestinal 19,106 4,256 — 23,362 Eye & Ear Care 26,007 2,796 — 28,803 Dermatologicals 22,698 671 — 23,369 Oral Care 23,811 2,217 — 26,028 Other OTC 1,478 9 — 1,487 Household Cleaning — — 21,691 21,691 Total segment revenues $ 172,080 $ 15,804 $ 21,691 $ 209,575 During the three months ended June 30, 2017 and 2016 , approximately 87.7% and 87.5% , respectively, of our total segment revenues were from customers in the United States. Other than the United States, no individual geographical area accounted for more than 10% of net sales in any of the periods presented. During the three months ended June 30, 2017 , our Canada and Australia sales accounted for approximately 3.8% and 4.1% , respectively, of our total segment revenues, while during the three months ended June 30, 2016 , approximately 4.7% and 5.0% , respectively, of our total segment revenues were attributable to sales to Canada and Australia. At June 30, 2017 and March 31, 2017 , approximately 96.5% of our consolidated goodwill and intangible assets were located in the United States and approximately 3.5% were located in Australia, the United Kingdom and Singapore. These consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: June 30, 2017 (In thousands) North American OTC International OTC Household Consolidated Goodwill $ 576,453 $ 32,753 $ 6,245 $ 615,451 Intangible assets Indefinite-lived 2,404,336 84,018 101,261 2,589,615 Finite-lived, net 281,784 6,376 20,498 308,658 Intangible assets, net 2,686,120 90,394 121,759 2,898,273 Total $ 3,262,573 $ 123,147 $ 128,004 $ 3,513,724 March 31, 2017 (In thousands) North American OTC International OTC Household Consolidated Goodwill $ 576,453 $ 32,554 $ 6,245 $ 615,252 Intangible assets Indefinite-lived 2,404,336 83,558 101,261 2,589,155 Finite-lived, net 287,056 6,468 20,934 314,458 Intangible assets, net 2,691,392 90,026 122,195 2,903,613 Total $ 3,267,845 $ 122,580 $ 128,440 $ 3,518,865

Condensed Consolidating Financi

Condensed Consolidating Financial Statements	3 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Financial Statements	Condensed Consolidating Financial Statements Prestige Brands Holdings, Inc., together with certain of our 100% owned subsidiaries, has fully and unconditionally guaranteed, on a joint and several basis, the obligations of Prestige Brands, Inc. (a 100% owned subsidiary of the Company) set forth in the indentures governing the 2016 Senior Notes and the 2013 Senior Notes, including the obligation to pay principal and interest with respect to the 2016 Senior Notes and the 2013 Senior Notes. The 100% owned subsidiaries of the Company that have guaranteed the 2016 Senior Notes and the 2013 Senior Notes are as follows: Prestige Services Corp., Prestige Brands Holdings, Inc. (a Virginia corporation), Prestige Brands International, Inc., Medtech Holdings, Inc., Medtech Products Inc., Medtech Personal Products Corporation, The Spic and Span Company, Blacksmith Brands, Inc., Insight Pharmaceuticals Corporation, Insight Pharmaceuticals, LLC, Practical Health Products, Inc., DenTek Holdings, Inc., C.B. Fleet Topco, LLC, C.B. Fleet Holdco, LLC, C.B.Fleet, LLC, C.B. Fleet Company, Incorporated, Peaks HBC Company, Inc., C.B. Fleet Investment Corporation, C.B.Fleet International, Inc., C.B. Fleet Holding Company, Incorporated, Medtech Online, Inc. and DenTek Oral Care, Inc. (collectively, the "Subsidiary Guarantors"). A significant portion of our operating income and cash flow is generated by our subsidiaries. As a result, funds necessary to meet Prestige Brands, Inc.'s debt service obligations are provided in part by distributions or advances from our subsidiaries. Under certain circumstances, contractual and legal restrictions, as well as the financial condition and operating requirements of our subsidiaries, could limit Prestige Brands, Inc.'s ability to obtain cash from our subsidiaries for the purpose of meeting our debt service obligations, including the payment of principal and interest on the 2016 Senior Notes and the 2013 Senior Notes. Although holders of the 2016 Senior Notes and the 2013 Senior Notes will be direct creditors of the guarantors of the 2016 Senior Notes and the 2013 Senior Notes by virtue of the guarantees, we have indirect subsidiaries located primarily in the United Kingdom, the Netherlands, Singapore and Australia (collectively, the "Non-Guarantor Subsidiaries") that have not guaranteed the 2016 Senior Notes or the 2013 Senior Notes, and such subsidiaries will not be obligated with respect to the 2016 Senior Notes or the 2013 Senior Notes. As a result, the claims of creditors of the Non-Guarantor Subsidiaries will effectively have priority with respect to the assets and earnings of such companies over the claims of the holders of the 2016 Senior Notes and the 2013 Senior Notes. Presented below are supplemental Condensed Consolidating Balance Sheets as of June 30, 2017 and March 31, 2017 , Condensed Consolidating Statements of Income and Comprehensive Income for the three months ended June 30, 2017 and 2016 , and Condensed Consolidating Statements of Cash Flows for the three months ended June 30, 2017 and 2016 . Such consolidating information includes separate columns for: a) Prestige Brands Holdings, Inc., the parent, b) Prestige Brands, Inc., the Issuer or the Borrower, c) Combined Subsidiary Guarantors, d) Combined Non-Guarantor Subsidiaries, and e) Elimination entries necessary to consolidate the Company and all of its subsidiaries. The Condensed Consolidating Financial Statements are presented using the equity method of accounting for investments in our 100% owned subsidiaries. Under the equity method, the investments in subsidiaries are recorded at cost and adjusted for our share of the subsidiaries' cumulative results of operations, capital contributions, distributions and other equity changes. The elimination entries principally eliminate investments in subsidiaries and intercompany balances and transactions. The financial information in this note should be read in conjunction with the Condensed Consolidated Financial Statements presented and other notes related thereto contained in this Quarterly Report on Form 10-Q. In the second quarter of fiscal 2017, the Company determined that it had incorrectly recorded certain intercompany transactions relating to the first quarter of fiscal 2017 in the condensed consolidating financial statements. This resulted in an overstatement of equity in earnings of subsidiaries for Prestige Brands, Inc. of $44.6 million and a net understatement of equity in earnings of subsidiaries for the eliminations of $44.6 million for the three months ended June 30, 2016. This item also resulted in corresponding adjustments to the investments in subsidiaries on the condensed consolidating balance sheet as of June 30, 2016 and adjustments to net income (loss) and equity in income of subsidiaries in the condensed consolidating statement of cash flows, although net cash provided by (used in) operating activities for the three months ended June 30, 2016 remained unchanged. These errors had no impact to the Company's consolidated balance sheet, consolidated statement of income or consolidated statement of cash flows. The Company assessed the materiality of these errors on the previously issued interim financial statements in accordance with SEC Staff Accounting Bulletin No. 99 and No. 108, and concluded that the errors were not material to the condensed consolidated financial statements for the three months ended June 30, 2016. The Company appropriately reflected the intercompany transactions in the condensed consolidating financial statements for the six months ended September 30, 2016, and we revised the comparative presentation of the condensed consolidating financial statements for the period ended June 30, 2016 below. Condensed Consolidating Statements of Income and Comprehensive Income Three Months Ended June 30, 2017 (In thousands) Prestige Brands Holdings, Inc. Prestige Brands, Inc., the issuer Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Revenues Net sales $ — $ 26,683 $ 212,912 $ 18,321 $ (1,429 ) $ 256,487 Other revenues — 63 248 517 (742 ) 86 Total revenues — 26,746 213,160 18,838 (2,171 ) 256,573 Cost of Sales Cost of sales excluding depreciation — 11,021 94,783 8,559 (2,606 ) 111,757 Cost of sales depreciation — — 1,340 — — 1,340 Cost of sales — 11,021 96,123 8,559 (2,606 ) 113,097 Gross profit — 15,725 117,037 10,279 435 143,476 Operating Expenses Advertising and promotion — 4,270 29,029 3,645 — 36,944 General and administrative 1,186 2,703 14,421 2,026 — 20,336 Depreciation and amortization 813 166 5,945 243 — 7,167 Total operating expenses 1,999 7,139 49,395 5,914 — 64,447 Operating income (loss) (1,999 ) 8,586 67,642 4,365 435 79,029 Other (income) expense Interest income (11,886 ) (21,117 ) (1,385 ) (998 ) 35,317 (69 ) Interest expense 8,374 26,408 25,560 1,385 (35,317 ) 26,410 Equity in (income) loss of subsidiaries (33,265 ) (31,754 ) (3,136 ) — 68,155 — Total other expense (income) (36,777 ) (26,463 ) 21,039 387 68,155 26,341 Income (loss) before income taxes 34,778 35,049 46,603 3,978 (67,720 ) 52,688 Provision for income taxes 1,019 1,203 15,865 842 — 18,929 Net income (loss) $ 33,759 $ 33,846 $ 30,738 $ 3,136 $ (67,720 ) $ 33,759 Comprehensive income (loss), net of tax: Currency translation adjustments 1,119 1,119 1,119 1,119 (3,357 ) 1,119 Unrecognized net gain (loss) on pension plans 1 1 1 — (2 ) 1 Total other comprehensive income (loss) 1,120 1,120 1,120 1,119 (3,359 ) 1,120 Comprehensive income (loss) $ 34,879 $ 34,966 $ 31,858 $ 4,255 $ (71,079 ) $ 34,879 Condensed Consolidating Statements of Income and Comprehensive Income Three Months Ended June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Revenues Net sales $ — $ 27,959 $ 168,205 $ 13,826 $ (1,220 ) $ 208,770 Other revenues — 75 801 486 (557 ) 805 Total revenues — 28,034 169,006 14,312 (1,777 ) 209,575 Cost of Sales Cost of sales — 12,086 71,462 6,000 (1,564 ) 87,984 Gross profit — 15,948 97,544 8,312 (213 ) 121,591 Operating Expenses Advertising and promotion — 4,745 20,804 2,086 — 27,635 General and administrative 1,937 2,188 14,314 1,018 — 19,457 Depreciation and amortization 920 151 5,633 128 — 6,832 Loss on divestitures — — 55,453 — — 55,453 Total operating expenses 2,857 7,084 96,204 3,232 — 109,377 Operating income (loss) (2,857 ) 8,864 1,340 5,080 (213 ) 12,214 Other (income) expense Interest income (11,967 ) (21,262 ) (1,274 ) (159 ) 34,605 (57 ) Interest expense 8,440 21,174 24,901 1,274 (34,605 ) 21,184 Equity in (income) loss of subsidiaries 5,738 13,259 (3,076 ) — (15,921 ) — Total other (income) expense 2,211 13,171 20,551 1,115 (15,921 ) 21,127 (Loss) income before income taxes (5,068 ) (4,307 ) (19,211 ) 3,965 15,708 (8,913 ) (Benefit) provision for income taxes 463 3,178 (7,912 ) 889 — (3,382 ) Net (loss) income $ (5,531 ) $ (7,485 ) $ (11,299 ) $ 3,076 $ 15,708 $ (5,531 ) Comprehensive (loss) income, net of tax: Currency translation adjustments (5,824 ) (5,824 ) (5,824 ) (5,824 ) 17,472 (5,824 ) Total other comprehensive (loss) income (5,824 ) (5,824 ) (5,824 ) (5,824 ) 17,472 (5,824 ) Comprehensive (loss) income $ (11,355 ) $ (13,309 ) $ (17,123 ) $ (2,748 ) $ 33,180 $ (11,355 ) Condensed Consolidating Balance Sheet June 30, 2017 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 6,176 $ — $ 4,467 $ 33,492 $ — $ 44,135 Accounts receivable, net — 12,684 106,028 16,013 — 134,725 Inventories — 16,399 92,857 9,979 (528 ) 118,707 Prepaid expenses and other current assets 6,295 848 21,921 1,594 — 30,658 Total current assets 12,471 29,931 225,273 61,078 (528 ) 328,225 Property, plant and equipment, net 7,148 407 42,354 560 — 50,469 Goodwill — 66,007 516,691 32,753 — 615,451 Intangible assets, net — 191,119 2,616,653 90,501 — 2,898,273 Other long-term assets 2,500 2,675 1,151 817 — 7,143 Intercompany receivables 1,524,730 2,434,924 2,020,627 195,602 (6,175,883 ) — Investment in subsidiary 1,742,236 2,430,790 281,433 — (4,454,459 ) — Total Assets $ 3,289,085 $ 5,155,853 $ 5,704,182 $ 381,311 $ (10,630,870 ) $ 3,899,561 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 2,461 $ 11,247 $ 45,194 $ 3,836 $ — $ 62,738 Accrued interest payable — 8,414 — — — 8,414 Other accrued liabilities 8,076 2,840 65,109 6,440 — 82,465 Total current liabilities 10,537 22,501 110,303 10,276 — 153,617 Long-term debt Principal amount — 2,172,000 — — — 2,172,000 Less unamortized debt costs — (26,591 ) — — — (26,591 ) Long-term debt, net — 2,145,409 — — — 2,145,409 Deferred income tax liabilities — 58,206 666,158 181 — 724,545 Other long-term liabilities — — 17,382 61 — 17,443 Intercompany payables 2,420,001 1,261,252 2,402,936 91,694 (6,175,883 ) — Total Liabilities 2,430,538 3,487,368 3,196,779 102,212 (6,175,883 ) 3,041,014 Stockholders' Equity Common stock 533 — — — — 533 Additional paid-in capital 460,401 1,280,947 2,183,644 269,234 (3,733,825 ) 460,401 Treasury stock, at cost (7,621 ) — — — — (7,621 ) Accumulated other comprehensive (loss) income, net of tax (25,232 ) (25,232 ) (25,232 ) (24,980 ) 75,444 (25,232 ) Retained earnings (accumulated deficit) 430,466 412,770 348,991 34,845 (796,606 ) 430,466 Total Stockholders' Equity 858,547 1,668,485 2,507,403 279,099 (4,454,987 ) 858,547 Total Liabilities and Stockholders' Equity $ 3,289,085 $ 5,155,853 $ 5,704,182 $ 381,311 $ (10,630,870 ) $ 3,899,561 Condensed Consolidating Balance Sheet March 31, 2017 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 6,168 $ — $ 4,984 $ 30,703 $ — $ 41,855 Accounts receivable, net — 15,787 105,403 15,552 — 136,742 Inventories — 16,484 89,255 10,833 (963 ) 115,609 Prepaid expenses and other current assets 15,072 245 23,444 1,467 — 40,228 Total current assets 21,240 32,516 223,086 58,555 (963 ) 334,434 Property, plant and equipment, net 7,300 439 42,260 596 — 50,595 Goodwill — 66,007 516,691 32,554 — 615,252 Intangible assets, net — 191,253 2,622,226 90,134 — 2,903,613 Other long-term assets 2,500 2,774 1,170 1,010 — 7,454 Intercompany receivables 1,510,308 2,477,928 1,832,286 193,609 (6,014,131 ) — Investment in subsidiary 1,708,095 2,397,916 276,933 — (4,382,944 ) — Total Assets $ 3,249,443 $ 5,168,833 $ 5,514,652 $ 376,458 $ (10,398,038 ) $ 3,911,348 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 2,150 $ 14,576 $ 49,025 $ 4,467 $ — $ 70,218 Accrued interest payable — 8,130 — — — 8,130 Other accrued liabilities 12,905 2,432 59,711 8,613 — 83,661 Total current liabilities 15,055 25,138 108,736 13,080 — 162,009 Long-term debt Principal amount — 2,222,000 — — — 2,222,000 Less unamortized debt costs — (28,268 ) — — — (28,268 ) Long-term debt, net — 2,193,732 — — — 2,193,732 Deferred income tax liabilities — 55,945 659,132 9 — 715,086 Other long-term liabilities — — 17,920 52 — 17,972 Intercompany payables 2,411,839 1,260,499 2,253,319 88,474 (6,014,131 ) — Total Liabilities 2,426,894 3,535,314 3,039,107 101,615 (6,014,131 ) 3,088,799 Stockholders' Equity Common stock 533 — — — — 533 Additional paid-in capital 458,255 1,280,947 2,183,644 269,234 (3,733,825 ) 458,255 Treasury stock, at cost (6,594 ) — — — — (6,594 ) Accumulated other comprehensive income (loss), net of tax (26,352 ) (26,352 ) (26,352 ) (26,100 ) 78,804 (26,352 ) Retained earnings (accumulated deficit) 396,707 378,924 318,253 31,709 (728,886 ) 396,707 Total Stockholders' Equity 822,549 1,633,519 2,475,545 274,843 (4,383,907 ) 822,549 Total Liabilities and Stockholders' Equity $ 3,249,443 $ 5,168,833 $ 5,514,652 $ 376,458 $ (10,398,038 ) $ 3,911,348 Condensed Consolidating Statement of Cash Flows Three Months Ended June 30, 2017 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Operating Activities Net income (loss) $ 33,759 $ 33,846 $ 30,738 $ 3,136 $ (67,720 ) $ 33,759 Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization 813 166 7,285 243 — 8,507 Loss on disposals of property and equipment — — 490 — — 490 Deferred income taxes — 2,261 7,026 (62 ) — 9,225 Amortization of debt origination costs — 1,746 — — — 1,746 Excess tax benefits from share-based awards 302 — — — — 302 Stock-based compensation costs 1,678 — — 35 — 1,713 Equity in income of subsidiaries (33,265 ) (31,754 ) (3,136 ) — 68,155 — Changes in operating assets and liabilities, net of effects from acquisitions: Accounts receivable — 2,133 (625 ) 35 — 1,543 Inventories — 85 (3,602 ) 1,053 (435 ) (2,899 ) Prepaid expenses and other current assets 8,777 (603 ) 1,523 (93 ) — 9,604 Accounts payable 271 (3,329 ) (4,250 ) (716 ) — (8,024 ) Accrued liabilities (4,674 ) 692 4,930 (2,506 ) — (1,558 ) Noncurrent assets and liabilities — — (287 ) — — (287 ) Net cash provided by operating activities 7,661 5,243 40,092 1,125 — 54,121 Investing Activities Purchases of property, plant and equipment (620 ) — (1,890 ) (44 ) — (2,554 ) Acquisition of Fleet escrow payment — 970 — — 970 Net cash used in investing activities (620 ) 970 (1,890 ) (44 ) — (1,584 ) Financing Activities Term loan repayments — (50,000 ) — — — (50,000 ) Proceeds from exercise of stock options 433 — — — — 433 Fair value of shares surrendered as payment of tax withholding (1,027 ) — — — — (1,027 ) Intercompany activity, net (6,439 ) 43,787 (38,719 ) 1,371 — Net cash (used in) provided by financing activities (7,033 ) (6,213 ) (38,719 ) 1,371 — (50,594 ) Effect of exchange rate changes on cash and cash equivalents — — — 337 — 337 Increase (decrease) in cash and cash equivalents 8 — (517 ) 2,789 — 2,280 Cash and cash equivalents - beginning of period 6,168 — 4,984 30,703 — 41,855 Cash and cash equivalents - end of period $ 6,176 $ — $ 4,467 $ 33,492 $ — $ 44,135 Condensed Consolidating Statement of Cash Flows Three Months Ended June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non-Guarantor Subsidiaries Eliminations Consolidated Operating Activities Net income (loss) $ (5,531 ) $ (7,485 ) $ (11,299 ) $ 3,076 $ 15,708 $ (5,531 ) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization 920 151 5,633 128 — 6,832 Loss on divestitures — — 55,453 — — 55,453 Deferred income taxes (9 ) 385 (10,089 ) 53 — (9,660 ) Amortization of debt origination costs — 2,231 — — — 2,231 Excess tax benefits from share-based awards 550 — — — — 550 Stock-based compensation costs 1,940 — — — — 1,940 Equity in income of subsidiaries 5,738 13,259 (3,076 ) — (15,921 ) — Changes in operating assets and liabilities, net of effects from acquisitions: Accounts receivable — 1,858 4,800 (1,507 ) — 5,151 Inventories — (606 ) (3,835 ) (99 ) 213 (4,327 ) Prepaid expenses and other current assets 6,299 (281 ) (697 ) 376 — 5,697 Accounts payable (1,556 ) (721 ) 109 (1,233 ) — (3,401 ) Accrued liabilities (4,294 ) 975 261 (576 ) — (3,634 ) Net cash provided by operating activities 4,057 9,766 37,260 218 — 51,301 Investing Activities Purchases of property, plant and equipment (225 ) (23 ) (596 ) (51 ) — (895 ) Net cash used in investing activities (225 ) (23 ) (596 ) (51 ) — (895 ) Financing Activities Term loan repayments — (50,000 ) — — — (50,000 ) Payments of debt origination costs — (9 ) — — — (9 ) Proceeds from exercise of stock options 3,405 — — — — 3,405 Fair value of shares surrendered as payment of tax withholding (1,395 ) — — — — (1,395 ) Intercompany activity, net (4,971 ) 40,266 (37,285 ) 1,990 — — Net cash (used in) provided by financing activities (2,961 ) (9,743 ) (37,285 ) 1,990 — (47,999 ) Effect of exchange rate changes on cash and cash equivalents — — — (760 ) — (760 ) Increase (decrease) in cash and cash equivalents 871 — (621 ) 1,397 — 1,647 Cash and cash equivalents - beginning of period 4,440 — 2,899 19,891 — 27,230 Cash and cash equivalents - end of period $ 5,311 $ — $ 2,278 $ 21,288 $ — $ 28,877

Subsequent Events

Subsequent Events	3 Months Ended
	Jun. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Pursuant to the 2005 Long-Term Equity Incentive Plan, each of the independent members of the Board of Directors received a grant of 2,564 RSUs on August 1, 2017. The RSUs are fully vested upon receipt of the award and will be settled by delivery to the director of one share of common stock of the Company for each vested RSU promptly following the earliest of the director's (i) death, (ii) disability or (iii) the six -month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability.

Business and Basis of Present26

Business and Basis of Presentation (Policies)	3 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. All significant intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented. Our fiscal year ends on March 31 st of each year. References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., “2018”) mean our fiscal year ending or ended on March 31 st of that year. Operating results for the three months ended June 30, 2017 are not necessarily indicative of results that may be expected for the fiscal year ending March 31, 2018 . These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2017 .
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, the calculation of pension expense in our defined benefit plans, and the recognition of income taxes using an estimated annual effective tax rate.
Reclassification	Reclassification In accordance with Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation (Topic 718) , we have reclassified cash flows on our Condensed Consolidated Statements of Cash Flows related to excess tax benefits from a financing activity to an operating activity for all periods presented.
Revenue Recognition	Revenue Recognition Revenues are recognized when the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the selling price is fixed or determinable, (iii) the product has been shipped and the customer takes ownership and assumes the risk of loss, and (iv) collection of the resulting receivable is reasonably assured. We have determined that these criteria are met and the transfer of the risk of loss generally occurs when the product is received by the customer, and, accordingly, we recognize revenue at that time. Provisions are made for estimated discounts related to customer payment terms and estimated product returns at the time of sale based on our historical experience. As is customary in the consumer products industry, we participate in the promotional programs of our customers to enhance the sale of our products. The cost of these promotional programs varies based on the actual number of units sold during a finite period of time. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. Estimates of the costs of these promotional programs are based on (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. We recognize the cost of such sales incentives by recording an estimate of such cost as a reduction of revenue, at the later of (a) the date the related revenue is recognized, or (b) the date when a particular sales incentive is offered. At the completion of a promotional program, the estimated amounts are adjusted to actual results. Due to the nature of the consumer products industry, we are required to estimate future product returns. Accordingly, we record an estimate of product returns concurrent with recording sales, which is made after analyzing (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising.
Cost of Sales	Cost of Sales Cost of sales includes product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs.
Advertising and Promotion Costs	Advertising and Promotion Costs Advertising and promotion costs are expensed as incurred. Allowances for distribution costs associated with products, including slotting fees, are recognized as a reduction of sales. Under these slotting fee distribution arrangements, the retailers allow our products to be placed on the stores' shelves in exchange for such fees.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In May 2017, the Financial Accounting Standards Board ("FASB") issued ASU 2017-09, Compensation - Stock Compensation (Topic 718) . The amendments provide guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting under Topic 718. The amendments in this update are effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. We adopted ASU 2017-09 retrospectively effective April 1, 2017, and the adoption did not have a material impact on our Financial Statements. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350) . The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairments tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on our Financial Statements and whether to early adopt this ASU. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting this guidance on our Financial Statements. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments . The amendments in this update provide clarification and guidance on eight cash flow classification issues. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU 2016-15 is not expected to have a material impact on our Financial Statements. In February 2016, the FASB issued ASU 2016-02, Leases. The amendments in this update include a new FASB Accounting Standards Codification ("ASC") Topic 842, which supersedes Topic 840. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted for all entities as of the beginning of interim or annual reporting periods. We are evaluating the impact of adopting this guidance on our Financial Statements. In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory . The amendments in this update more closely align the measurement of inventory in GAAP with the measurement of inventory in International Financial Reporting Standards, under which an entity should measure inventory at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The adoption of ASU 2015-11, effective April 1, 2017, did not have a material impact on our Financial Statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers - Topic 606 , which supersedes the revenue recognition requirements in FASB ASC 605. The new guidance will eliminate industry-specific revenue recognition guidance under current GAAP and replace it with a principle-based approach for determining revenue recognition. This ASU primarily states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. This ASU will also require additional disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. In August 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU 2014-09 from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. With the issuance of ASU 2016-08 in March 2016, the FASB clarified the implementation guidance on principals versus agent considerations in FASB ASC 606. In April 2016, the FASB issued ASU 2016-10, which clarified implementation guidance on identifying performance obligations and licensing in FASB ASC 606. Certain narrow aspects of the guidance in FASB ASC 606 were amended with the issuances of ASU 2016-12 in May 2016 and ASU 2016-20 in December 2016. We expect to adopt this guidance when effective using the modified retrospective transition method. We have made substantial progress in completing our review of the impact of this guidance. Our implementation approach includes performing a detailed study of the various types of agreements that we have with our customers and assessing conformance of our current accounting practices with the new standard. We currently do not expect this new guidance to have a material impact on our financial statements, revenue recognition practices, or our internal controls. We continue to monitor additional amendments, clarifications and interpretations issued by the FASB that may affect our current conclusions.

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Jun. 30, 2017
Business Combinations [Abstract]
Allocation of Assets Acquired and Liabilities Assumed	The following table summarizes our allocation of the assets acquired and liabilities assumed as of the January 26, 2017 acquisition date. (In thousands) January 26, 2017 Cash $ 19,884 Accounts receivable 25,293 Inventories 20,812 Prepaid expenses and other current assets 17,024 Property, plant and equipment, net 38,661 Goodwill 268,577 Intangible assets, net 747,600 Other long-term assets 1,137 Total assets acquired 1,138,988 Accounts payable 10,412 Accrued expenses 22,895 Deferred income taxes - long term 261,555 Other long term liabilities 20,403 Total liabilities assumed 315,265 Total purchase price $ 823,723
Schedule of Pro Forma Information	The following table provides our unaudited pro forma revenues, net income and net income per basic and diluted common share had the results of Fleet's operations been included in our operations commencing on April 1, 2016, based on available information related to Fleet's operations. This pro forma information is not necessarily indicative either of the combined results of operations that actually would have been realized by us had the Fleet acquisition been consummated at the beginning of the period for which the pro forma information is presented, or of future results. Three Months Ended June 30, 2016 (In thousands, except per share data) (Unaudited) Revenues $ 260,776 Net income $ (5,930 ) Earnings per share: Basic EPS $ (0.11 ) Diluted EPS $ (0.11 )

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Jun. 30, 2017
Inventory Disclosure [Abstract]
Inventories	Inventories consist of the following: (In thousands) June 30, March 31, Components of Inventories, net Packaging and raw materials $ 12,887 $ 9,984 Work in process 366 369 Finished goods 105,454 105,256 Inventories $ 118,707 $ 115,609

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Reconciliation of the Activity Affecting Goodwill	A reconciliation of the activity affecting goodwill by operating segment is as follows: (In thousands) North American OTC Healthcare International OTC Healthcare Household Cleaning Consolidated Balance — March 31, 2017 $ 576,453 $ 32,554 $ 6,245 $ 615,252 Adjustments — — — — Effects of foreign currency exchange rates — 199 — 199 Balance — June 30, 2017 $ 576,453 $ 32,753 $ 6,245 $ 615,451

Intangible Assets, net (Tables)

Intangible Assets, net (Tables)	3 Months Ended
	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Reconciliation of the Activity Affecting Finite Lived Intangible Assets	A reconciliation of the activity affecting intangible assets, net is as follows: (In thousands) Indefinite Lived Trademarks Finite Lived Totals Gross Carrying Amounts Balance — March 31, 2017 $ 2,589,155 $ 441,801 $ 3,030,956 Effects of foreign currency exchange rates 460 60 520 Balance — June 30, 2017 2,589,615 441,861 3,031,476 Accumulated Amortization Balance — March 31, 2017 — 127,343 127,343 Additions — 5,854 5,854 Effects of foreign currency exchange rates — 6 6 Balance — June 30, 2017 — 133,203 133,203 Intangible assets, net - June 30, 2017 $ 2,589,615 $ 308,658 $ 2,898,273
Reconciliation of the Activity Affecting Indefinite Lived Intangible Assets	A reconciliation of the activity affecting intangible assets, net is as follows: (In thousands) Indefinite Lived Trademarks Finite Lived Totals Gross Carrying Amounts Balance — March 31, 2017 $ 2,589,155 $ 441,801 $ 3,030,956 Effects of foreign currency exchange rates 460 60 520 Balance — June 30, 2017 2,589,615 441,861 3,031,476 Accumulated Amortization Balance — March 31, 2017 — 127,343 127,343 Additions — 5,854 5,854 Effects of foreign currency exchange rates — 6 6 Balance — June 30, 2017 — 133,203 133,203 Intangible assets, net - June 30, 2017 $ 2,589,615 $ 308,658 $ 2,898,273

Other Accrued Liabilities (Tabl

Other Accrued Liabilities (Tables)	3 Months Ended
	Jun. 30, 2017
Payables and Accruals [Abstract]
Other Accrued Liabilities	Other accrued liabilities consist of the following: (In thousands) June 30, March 31, Accrued marketing costs $ 35,284 $ 29,384 Accrued compensation costs 8,973 15,535 Accrued broker commissions 1,096 1,782 Income taxes payable 38 3,840 Accrued professional fees 2,168 2,412 Deferred rent 482 492 Accrued production costs 6,883 4,580 Accrued lease termination costs 730 843 Income tax related payable 19,000 19,000 Other accrued liabilities 7,811 5,793 $ 82,465 $ 83,661

Long-Term Debt (Tables)

Long-Term Debt (Tables)	3 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Long-term debt consists of the following, as of the dates indicated: (In thousands, except percentages) June 30, March 31, 2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year. The 2016 Senior Notes mature on March 1, 2024. $ 350,000 $ 350,000 2013 Senior Notes bearing interest at 5.375%, with interest payable on June 15 and December 15 of each year. The 2013 Senior Notes mature on December 15, 2021. 400,000 400,000 2012 Term B-4 Loans bearing interest at our option at either LIBOR plus a margin of 2.75%, with a LIBOR floor of 0.75%, or a base rate plus a margin (with a margin step-down to 2.50%) due on January 26, 2024. 1,332,000 1,382,000 2012 ABL Revolver bearing interest at our option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on January 26, 2022. 90,000 90,000 Total long-term debt (including current portion) 2,172,000 2,222,000 Current portion of long-term debt — — Long-term debt 2,172,000 2,222,000 Less: unamortized debt costs (26,591 ) (28,268 ) Long-term debt, net $ 2,145,409 $ 2,193,732
Aggregate Future Principal Payments	As of June 30, 2017 , aggregate future principal payments required in accordance with the terms of the 2012 Term B-4 Loans, 2012 ABL Revolver and the indentures governing the 6.375% senior unsecured notes due 2024 (the "2016 Senior Notes") and the 5.375% senior unsecured notes due 2021 (the "2013 Senior Notes") are as follows: (In thousands) Year Ending March 31, Amount 2018 (remaining nine months ending March 31, 2018) $ — 2019 — 2020 — 2021 — 2022 490,000 Thereafter 1,682,000 $ 2,172,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Summary of Carry Amounts and Fair Value Measurements	As such, the 2016 Senior Notes, the 2013 Senior Notes, the 2012 Term B-4 Loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these borrowings at June 30, 2017 and March 31, 2017 ). June 30, 2017 March 31, 2017 (In thousands) Carrying Value Fair Value Carrying Value Fair Value 2016 Senior Notes $ 350,000 $ 373,188 $ 350,000 $ 367,500 2013 Senior Notes 400,000 412,500 400,000 409,000 2012 Term B-4 Loans 1,332,000 1,336,995 1,382,000 1,395,820 2012 ABL Revolver 90,000 90,000 90,000 90,000

Accumulated Other Comprehensi34

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Jun. 30, 2017
Stockholders' Equity Note [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The table below presents accumulated other comprehensive loss (“AOCI”), which affects equity and results from recognized transactions and other economic events, other than transactions with owners in their capacity as owners. AOCI consisted of the following at June 30, 2017 and March 31, 2017 : June 30, March 31, (In thousands) 2017 2017 Components of Accumulated Other Comprehensive Loss Cumulative translation adjustment $ (24,981 ) $ (26,100 ) Unrecognized net loss on pension plans (251 ) (252 ) Accumulated other comprehensive loss, net of tax $ (25,232 ) $ (26,352 )

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Jun. 30, 2017
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended June 30, (In thousands, except per share data) 2017 2016 Numerator Net income (loss) $ 33,759 $ (5,531 ) Denominator Denominator for basic earnings per share — weighted average shares outstanding 53,038 52,881 Dilutive effect of unvested restricted stock units and options issued to employees and directors 471 — Denominator for diluted earnings per share 53,509 52,881 Earnings per Common Share: Basic net earnings (loss) per share $ 0.64 $ (0.10 ) Diluted net earnings (loss) per share $ 0.63 $ (0.10 )

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Restricted Shares	A summary of the Company's RSUs granted under the Plan is presented below: RSUs Shares (in thousands) Weighted- Average Grant-Date Fair Value Three months ended June 30, 2016 Vested and nonvested at March 31, 2016 467.8 $ 35.22 Granted 49.4 57.16 Vested and issued (75.6 ) 31.36 Forfeited (76.2 ) 39.93 Vested and nonvested at June 30, 2016 365.4 38.00 Vested at June 30, 2016 70.2 14.89 Three months ended June 30, 2017 Vested and nonvested at March 31, 2017 350.1 $ 39.29 Granted 90.4 56.11 Vested and issued (50.8 ) 34.28 Forfeited (2.3 ) 50.06 Vested and nonvested at June 30, 2017 387.4 43.81 Vested at June 30, 2017 63.7 20.31
Fair Value of Options Granted	The weighted-average grant-date fair values of the options granted during the three months ended June 30, 2017 and 2016 were $21.20 and $22.26 , respectively. Three months ended June 30, 2017 2016 Expected volatility 35.2 % 37.8 % Expected dividends $ — $ — Expected term in years 6.0 6.0 Risk-free rate 2.2 % 1.7 %
Stock Option Activity	A summary of option activity under the Plan is as follows: Options Shares (in thousands) Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Three months ended June 30, 2016 Outstanding at March 31, 2016 727.7 $ 30.70 Granted 224.8 57.18 Exercised (105.7 ) 32.20 Forfeited or expired (45.5 ) 37.34 Outstanding at June 30, 2016 801.3 37.55 8.0 $ 14,700 Exercisable at June 30, 2016 386.4 25.20 6.7 $ 11,669 Three months ended June 30, 2017 Outstanding at March 31, 2017 772.3 $ 37.70 Granted 182.8 56.11 Exercised (13.8 ) 31.35 Forfeited or expired (5.8 ) 32.64 Outstanding at June 30, 2017 935.5 41.42 7.7 $ 12,123 Exercisable at June 30, 2017 527.3 31.95 6.5 $ 11,305

Employee Retirement Plans (Tabl

Employee Retirement Plans (Tables)	3 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Primary Components of Net Periodic Benefits	The primary components of Net Periodic Benefits consist of the following: Period Ended (In thousands) June 30, 2017 Interest cost $ 629 Expected return on assets (726 ) Net periodic benefit cost (income) $ (97 )

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Purchase Commitments Minimum Amounts Set Forth	We have supply agreements for the manufacture of some of our products. The following table shows the minimum amounts that we are committed to pay under these agreements: (In thousands) Year Ending March 31, Amount 2018 (Remaining nine months ending March 31, 2018) 4,257 2019 9,082 2020 9,859 2021 9,300 2022 9,300 Thereafter 2,300 $ 44,098

Business Segments (Tables)

Business Segments (Tables)	3 Months Ended
	Jun. 30, 2017
Segment Reporting [Abstract]
Information about our Operating and Reportable Segments	The tables below summarize information about our reportable segments. Three Months Ended June 30, 2017 (In thousands) North American OTC International OTC Household Cleaning Consolidated Total segment revenues* $ 215,815 $ 20,898 $ 19,860 $ 256,573 Cost of sales 86,501 9,950 16,646 113,097 Gross profit 129,314 10,948 3,214 143,476 Advertising and promotion 32,808 3,690 446 36,944 Contribution margin $ 96,506 $ 7,258 $ 2,768 106,532 Other operating expenses 27,503 Operating income 79,029 Other expense 26,341 Income before income taxes 52,688 Provision for income taxes 18,929 Net income $ 33,759 * Intersegment revenues of $1.4 million were eliminated from the North American OTC Healthcare segment. Three Months Ended June 30, 2016 (In thousands) North American OTC International OTC Household Cleaning Consolidated Total segment revenues* $ 172,080 $ 15,804 $ 21,691 $ 209,575 Cost of sales** 64,234 6,948 16,802 87,984 Gross profit 107,846 8,856 4,889 121,591 Advertising and promotion 25,040 2,124 471 27,635 Contribution margin $ 82,806 $ 6,732 $ 4,418 93,956 Other operating expenses*** 81,742 Operating income 12,214 Other expense 21,127 Loss before income taxes (8,913 ) Benefit for income taxes (3,382 ) Net loss $ (5,531 ) * Intersegment revenues of $1.2 million were eliminated from the North American OTC Healthcare segment. **Certain immaterial amounts related to cost of sales were reclassified between the International OTC Healthcare segment and the North American OTC Healthcare segment. There were no changes to the condensed consolidated financial statements for any periods presented. **
Information about our Revenues from Similar Product Groups	The tables below summarize information about our segment revenues from similar product groups. Three Months Ended June 30, 2017 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 29,290 $ 509 $ — $ 29,799 Cough & Cold 17,410 4,613 — 22,023 Women's Health 63,145 3,594 — 66,739 Gastrointestinal 30,430 5,733 — 36,163 Eye & Ear Care 25,271 3,055 — 28,326 Dermatologicals 24,131 501 — 24,632 Oral Care 24,892 2,892 — 27,784 Other OTC 1,246 1 — 1,247 Household Cleaning — — 19,860 19,860 Total segment revenues $ 215,815 $ 20,898 $ 19,860 $ 256,573 Three Months Ended June 30, 2016 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 28,126 $ 527 $ — $ 28,653 Cough & Cold 17,967 4,392 — 22,359 Women's Health 32,887 936 — 33,823 Gastrointestinal 19,106 4,256 — 23,362 Eye & Ear Care 26,007 2,796 — 28,803 Dermatologicals 22,698 671 — 23,369 Oral Care 23,811 2,217 — 26,028 Other OTC 1,478 9 — 1,487 Household Cleaning — — 21,691 21,691 Total segment revenues $ 172,080 $ 15,804 $ 21,691 $ 209,575
Allocation of Long-Term Assets to Segments	These consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: June 30, 2017 (In thousands) North American OTC International OTC Household Consolidated Goodwill $ 576,453 $ 32,753 $ 6,245 $ 615,451 Intangible assets Indefinite-lived 2,404,336 84,018 101,261 2,589,615 Finite-lived, net 281,784 6,376 20,498 308,658 Intangible assets, net 2,686,120 90,394 121,759 2,898,273 Total $ 3,262,573 $ 123,147 $ 128,004 $ 3,513,724 March 31, 2017 (In thousands) North American OTC International OTC Household Consolidated Goodwill $ 576,453 $ 32,554 $ 6,245 $ 615,252 Intangible assets Indefinite-lived 2,404,336 83,558 101,261 2,589,155 Finite-lived, net 287,056 6,468 20,934 314,458 Intangible assets, net 2,691,392 90,026 122,195 2,903,613 Total $ 3,267,845 $ 122,580 $ 128,440 $ 3,518,865

Condensed Consolidating Finan40

Condensed Consolidating Financial Statements (Tables)	3 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Statements of Income and Comprehensive Income	Condensed Consolidating Statements of Income and Comprehensive Income Three Months Ended June 30, 2017 (In thousands) Prestige Brands Holdings, Inc. Prestige Brands, Inc., the issuer Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Revenues Net sales $ — $ 26,683 $ 212,912 $ 18,321 $ (1,429 ) $ 256,487 Other revenues — 63 248 517 (742 ) 86 Total revenues — 26,746 213,160 18,838 (2,171 ) 256,573 Cost of Sales Cost of sales excluding depreciation — 11,021 94,783 8,559 (2,606 ) 111,757 Cost of sales depreciation — — 1,340 — — 1,340 Cost of sales — 11,021 96,123 8,559 (2,606 ) 113,097 Gross profit — 15,725 117,037 10,279 435 143,476 Operating Expenses Advertising and promotion — 4,270 29,029 3,645 — 36,944 General and administrative 1,186 2,703 14,421 2,026 — 20,336 Depreciation and amortization 813 166 5,945 243 — 7,167 Total operating expenses 1,999 7,139 49,395 5,914 — 64,447 Operating income (loss) (1,999 ) 8,586 67,642 4,365 435 79,029 Other (income) expense Interest income (11,886 ) (21,117 ) (1,385 ) (998 ) 35,317 (69 ) Interest expense 8,374 26,408 25,560 1,385 (35,317 ) 26,410 Equity in (income) loss of subsidiaries (33,265 ) (31,754 ) (3,136 ) — 68,155 — Total other expense (income) (36,777 ) (26,463 ) 21,039 387 68,155 26,341 Income (loss) before income taxes 34,778 35,049 46,603 3,978 (67,720 ) 52,688 Provision for income taxes 1,019 1,203 15,865 842 — 18,929 Net income (loss) $ 33,759 $ 33,846 $ 30,738 $ 3,136 $ (67,720 ) $ 33,759 Comprehensive income (loss), net of tax: Currency translation adjustments 1,119 1,119 1,119 1,119 (3,357 ) 1,119 Unrecognized net gain (loss) on pension plans 1 1 1 — (2 ) 1 Total other comprehensive income (loss) 1,120 1,120 1,120 1,119 (3,359 ) 1,120 Comprehensive income (loss) $ 34,879 $ 34,966 $ 31,858 $ 4,255 $ (71,079 ) $ 34,879 Condensed Consolidating Statements of Income and Comprehensive Income Three Months Ended June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Revenues Net sales $ — $ 27,959 $ 168,205 $ 13,826 $ (1,220 ) $ 208,770 Other revenues — 75 801 486 (557 ) 805 Total revenues — 28,034 169,006 14,312 (1,777 ) 209,575 Cost of Sales Cost of sales — 12,086 71,462 6,000 (1,564 ) 87,984 Gross profit — 15,948 97,544 8,312 (213 ) 121,591 Operating Expenses Advertising and promotion — 4,745 20,804 2,086 — 27,635 General and administrative 1,937 2,188 14,314 1,018 — 19,457 Depreciation and amortization 920 151 5,633 128 — 6,832 Loss on divestitures — — 55,453 — — 55,453 Total operating expenses 2,857 7,084 96,204 3,232 — 109,377 Operating income (loss) (2,857 ) 8,864 1,340 5,080 (213 ) 12,214 Other (income) expense Interest income (11,967 ) (21,262 ) (1,274 ) (159 ) 34,605 (57 ) Interest expense 8,440 21,174 24,901 1,274 (34,605 ) 21,184 Equity in (income) loss of subsidiaries 5,738 13,259 (3,076 ) — (15,921 ) — Total other (income) expense 2,211 13,171 20,551 1,115 (15,921 ) 21,127 (Loss) income before income taxes (5,068 ) (4,307 ) (19,211 ) 3,965 15,708 (8,913 ) (Benefit) provision for income taxes 463 3,178 (7,912 ) 889 — (3,382 ) Net (loss) income $ (5,531 ) $ (7,485 ) $ (11,299 ) $ 3,076 $ 15,708 $ (5,531 ) Comprehensive (loss) income, net of tax: Currency translation adjustments (5,824 ) (5,824 ) (5,824 ) (5,824 ) 17,472 (5,824 ) Total other comprehensive (loss) income (5,824 ) (5,824 ) (5,824 ) (5,824 ) 17,472 (5,824 ) Comprehensive (loss) income $ (11,355 ) $ (13,309 ) $ (17,123 ) $ (2,748 ) $ 33,180 $ (11,355 )
Condensed Consolidating Balance Sheet	Condensed Consolidating Balance Sheet June 30, 2017 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 6,176 $ — $ 4,467 $ 33,492 $ — $ 44,135 Accounts receivable, net — 12,684 106,028 16,013 — 134,725 Inventories — 16,399 92,857 9,979 (528 ) 118,707 Prepaid expenses and other current assets 6,295 848 21,921 1,594 — 30,658 Total current assets 12,471 29,931 225,273 61,078 (528 ) 328,225 Property, plant and equipment, net 7,148 407 42,354 560 — 50,469 Goodwill — 66,007 516,691 32,753 — 615,451 Intangible assets, net — 191,119 2,616,653 90,501 — 2,898,273 Other long-term assets 2,500 2,675 1,151 817 — 7,143 Intercompany receivables 1,524,730 2,434,924 2,020,627 195,602 (6,175,883 ) — Investment in subsidiary 1,742,236 2,430,790 281,433 — (4,454,459 ) — Total Assets $ 3,289,085 $ 5,155,853 $ 5,704,182 $ 381,311 $ (10,630,870 ) $ 3,899,561 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 2,461 $ 11,247 $ 45,194 $ 3,836 $ — $ 62,738 Accrued interest payable — 8,414 — — — 8,414 Other accrued liabilities 8,076 2,840 65,109 6,440 — 82,465 Total current liabilities 10,537 22,501 110,303 10,276 — 153,617 Long-term debt Principal amount — 2,172,000 — — — 2,172,000 Less unamortized debt costs — (26,591 ) — — — (26,591 ) Long-term debt, net — 2,145,409 — — — 2,145,409 Deferred income tax liabilities — 58,206 666,158 181 — 724,545 Other long-term liabilities — — 17,382 61 — 17,443 Intercompany payables 2,420,001 1,261,252 2,402,936 91,694 (6,175,883 ) — Total Liabilities 2,430,538 3,487,368 3,196,779 102,212 (6,175,883 ) 3,041,014 Stockholders' Equity Common stock 533 — — — — 533 Additional paid-in capital 460,401 1,280,947 2,183,644 269,234 (3,733,825 ) 460,401 Treasury stock, at cost (7,621 ) — — — — (7,621 ) Accumulated other comprehensive (loss) income, net of tax (25,232 ) (25,232 ) (25,232 ) (24,980 ) 75,444 (25,232 ) Retained earnings (accumulated deficit) 430,466 412,770 348,991 34,845 (796,606 ) 430,466 Total Stockholders' Equity 858,547 1,668,485 2,507,403 279,099 (4,454,987 ) 858,547 Total Liabilities and Stockholders' Equity $ 3,289,085 $ 5,155,853 $ 5,704,182 $ 381,311 $ (10,630,870 ) $ 3,899,561 Condensed Consolidating Balance Sheet March 31, 2017 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 6,168 $ — $ 4,984 $ 30,703 $ — $ 41,855 Accounts receivable, net — 15,787 105,403 15,552 — 136,742 Inventories — 16,484 89,255 10,833 (963 ) 115,609 Prepaid expenses and other current assets 15,072 245 23,444 1,467 — 40,228 Total current assets 21,240 32,516 223,086 58,555 (963 ) 334,434 Property, plant and equipment, net 7,300 439 42,260 596 — 50,595 Goodwill — 66,007 516,691 32,554 — 615,252 Intangible assets, net — 191,253 2,622,226 90,134 — 2,903,613 Other long-term assets 2,500 2,774 1,170 1,010 — 7,454 Intercompany receivables 1,510,308 2,477,928 1,832,286 193,609 (6,014,131 ) — Investment in subsidiary 1,708,095 2,397,916 276,933 — (4,382,944 ) — Total Assets $ 3,249,443 $ 5,168,833 $ 5,514,652 $ 376,458 $ (10,398,038 ) $ 3,911,348 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 2,150 $ 14,576 $ 49,025 $ 4,467 $ — $ 70,218 Accrued interest payable — 8,130 — — — 8,130 Other accrued liabilities 12,905 2,432 59,711 8,613 — 83,661 Total current liabilities 15,055 25,138 108,736 13,080 — 162,009 Long-term debt Principal amount — 2,222,000 — — — 2,222,000 Less unamortized debt costs — (28,268 ) — — — (28,268 ) Long-term debt, net — 2,193,732 — — — 2,193,732 Deferred income tax liabilities — 55,945 659,132 9 — 715,086 Other long-term liabilities — — 17,920 52 — 17,972 Intercompany payables 2,411,839 1,260,499 2,253,319 88,474 (6,014,131 ) — Total Liabilities 2,426,894 3,535,314 3,039,107 101,615 (6,014,131 ) 3,088,799 Stockholders' Equity Common stock 533 — — — — 533 Additional paid-in capital 458,255 1,280,947 2,183,644 269,234 (3,733,825 ) 458,255 Treasury stock, at cost (6,594 ) — — — — (6,594 ) Accumulated other comprehensive income (loss), net of tax (26,352 ) (26,352 ) (26,352 ) (26,100 ) 78,804 (26,352 ) Retained earnings (accumulated deficit) 396,707 378,924 318,253 31,709 (728,886 ) 396,707 Total Stockholders' Equity 822,549 1,633,519 2,475,545 274,843 (4,383,907 ) 822,549 Total Liabilities and Stockholders' Equity $ 3,249,443 $ 5,168,833 $ 5,514,652 $ 376,458 $ (10,398,038 ) $ 3,911,348
Condensed Consolidating Statement of Cash Flows	Condensed Consolidating Statement of Cash Flows Three Months Ended June 30, 2017 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Operating Activities Net income (loss) $ 33,759 $ 33,846 $ 30,738 $ 3,136 $ (67,720 ) $ 33,759 Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization 813 166 7,285 243 — 8,507 Loss on disposals of property and equipment — — 490 — — 490 Deferred income taxes — 2,261 7,026 (62 ) — 9,225 Amortization of debt origination costs — 1,746 — — — 1,746 Excess tax benefits from share-based awards 302 — — — — 302 Stock-based compensation costs 1,678 — — 35 — 1,713 Equity in income of subsidiaries (33,265 ) (31,754 ) (3,136 ) — 68,155 — Changes in operating assets and liabilities, net of effects from acquisitions: Accounts receivable — 2,133 (625 ) 35 — 1,543 Inventories — 85 (3,602 ) 1,053 (435 ) (2,899 ) Prepaid expenses and other current assets 8,777 (603 ) 1,523 (93 ) — 9,604 Accounts payable 271 (3,329 ) (4,250 ) (716 ) — (8,024 ) Accrued liabilities (4,674 ) 692 4,930 (2,506 ) — (1,558 ) Noncurrent assets and liabilities — — (287 ) — — (287 ) Net cash provided by operating activities 7,661 5,243 40,092 1,125 — 54,121 Investing Activities Purchases of property, plant and equipment (620 ) — (1,890 ) (44 ) — (2,554 ) Acquisition of Fleet escrow payment — 970 — — 970 Net cash used in investing activities (620 ) 970 (1,890 ) (44 ) — (1,584 ) Financing Activities Term loan repayments — (50,000 ) — — — (50,000 ) Proceeds from exercise of stock options 433 — — — — 433 Fair value of shares surrendered as payment of tax withholding (1,027 ) — — — — (1,027 ) Intercompany activity, net (6,439 ) 43,787 (38,719 ) 1,371 — Net cash (used in) provided by financing activities (7,033 ) (6,213 ) (38,719 ) 1,371 — (50,594 ) Effect of exchange rate changes on cash and cash equivalents — — — 337 — 337 Increase (decrease) in cash and cash equivalents 8 — (517 ) 2,789 — 2,280 Cash and cash equivalents - beginning of period 6,168 — 4,984 30,703 — 41,855 Cash and cash equivalents - end of period $ 6,176 $ — $ 4,467 $ 33,492 $ — $ 44,135 Condensed Consolidating Statement of Cash Flows Three Months Ended June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non-Guarantor Subsidiaries Eliminations Consolidated Operating Activities Net income (loss) $ (5,531 ) $ (7,485 ) $ (11,299 ) $ 3,076 $ 15,708 $ (5,531 ) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization 920 151 5,633 128 — 6,832 Loss on divestitures — — 55,453 — — 55,453 Deferred income taxes (9 ) 385 (10,089 ) 53 — (9,660 ) Amortization of debt origination costs — 2,231 — — — 2,231 Excess tax benefits from share-based awards 550 — — — — 550 Stock-based compensation costs 1,940 — — — — 1,940 Equity in income of subsidiaries 5,738 13,259 (3,076 ) — (15,921 ) — Changes in operating assets and liabilities, net of effects from acquisitions: Accounts receivable — 1,858 4,800 (1,507 ) — 5,151 Inventories — (606 ) (3,835 ) (99 ) 213 (4,327 ) Prepaid expenses and other current assets 6,299 (281 ) (697 ) 376 — 5,697 Accounts payable (1,556 ) (721 ) 109 (1,233 ) — (3,401 ) Accrued liabilities (4,294 ) 975 261 (576 ) — (3,634 ) Net cash provided by operating activities 4,057 9,766 37,260 218 — 51,301 Investing Activities Purchases of property, plant and equipment (225 ) (23 ) (596 ) (51 ) — (895 ) Net cash used in investing activities (225 ) (23 ) (596 ) (51 ) — (895 ) Financing Activities Term loan repayments — (50,000 ) — — — (50,000 ) Payments of debt origination costs — (9 ) — — — (9 ) Proceeds from exercise of stock options 3,405 — — — — 3,405 Fair value of shares surrendered as payment of tax withholding (1,395 ) — — — — (1,395 ) Intercompany activity, net (4,971 ) 40,266 (37,285 ) 1,990 — — Net cash (used in) provided by financing activities (2,961 ) (9,743 ) (37,285 ) 1,990 — (47,999 ) Effect of exchange rate changes on cash and cash equivalents — — — (760 ) — (760 ) Increase (decrease) in cash and cash equivalents 871 — (621 ) 1,397 — 1,647 Cash and cash equivalents - beginning of period 4,440 — 2,899 19,891 — 27,230 Cash and cash equivalents - end of period $ 5,311 $ — $ 2,278 $ 21,288 $ — $ 28,877

Business and Basis of Present41

Business and Basis of Presentation (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Ownership percentage, subsidiaries	100.00%
Warehousing, shipping and handling, and storage costs	$ 13.5	$ 10.5

Acquisitions (Narrative) (Detai

Acquisitions (Narrative) (Details) - USD ($)	Jan. 26, 2017	Jun. 30, 2017	Mar. 31, 2017
Business Acquisition [Line Items]
Goodwill		$ 615,451,000	$ 615,252,000
C.B. Fleet Company, Inc.
Business Acquisition [Line Items]
Purchase price	$ 823,700,000
Non-amortizable intangible assets	648,700,000
Amortizable intangible assets	$ 98,900,000
Purchased amortizable intangible assets, weighted average useful life	18 years 8 months 12 days
Goodwill	$ 268,577,000
Term Loans | C.B. Fleet Company, Inc.
Business Acquisition [Line Items]
Debt instrument, face amount	$ 740,000,000

Acquisitions (Allocation of Ass

Acquisitions (Allocation of Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017	Jan. 26, 2017
Purchase Price
Goodwill	$ 615,451	$ 615,252
C.B. Fleet Company, Inc.
Purchase Price
Cash acquired			$ 19,884
Accounts receivable			25,293
Inventories			20,812
Prepaids and other current assets			17,024
Property, plant and equipment, net			38,661
Goodwill			268,577
Intangible assets, net			747,600
Other long-term assets			1,137
Total assets acquired			1,138,988
Accounts payable			10,412
Accrued expenses			22,895
Deferred income taxes - long term			261,555
Other long term liabilities			20,403
Total liabilities assumed			315,265
Total purchase price			$ 823,723

Acquisitions (Pro Forma) (Detai

Acquisitions (Pro Forma) (Details) - C.B. Fleet Company, Inc. $ / shares in Units, $ in Thousands	3 Months Ended
	Jun. 30, 2017USD ($)$ / shares
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Revenues | $	$ 260,776
Net income | $	$ (5,930)
Earnings per share:
Basic EPS (in dollars per share) | $ / shares	$ (0.11)
Diluted EPS (in dollars per share) | $ / shares	$ (0.11)

Divestitures (Narrative) (Detai

Divestitures (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Long Lived Assets Held-for-sale [Line Items]
Pre-tax loss (gain) on sales	$ 0	$ 55,453
Disposal group, held-for-sale, not discontinued operations | Pediacare, New Skin and Fiber Choice | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare
Long Lived Assets Held-for-sale [Line Items]
Pre-tax loss (gain) on sales		$ 55,500

Inventories (Components of Inv

Inventories (Components of Inventories) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017
Inventory Disclosure [Abstract]
Packaging and raw materials	$ 12,887	$ 9,984
Work in process	366	369
Finished goods	105,454	105,256
Inventories	118,707	115,609
Inventory valuation reserves related to obsolete and slow-moving inventory	$ 4,900	$ 6,600

Goodwill (Schedule of Segment G

Goodwill (Schedule of Segment Goodwill) (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2017USD ($)
Goodwill [Roll Forward]
Balance — March 31, 2017	$ 615,252
Adjustments	0
Effects of foreign currency exchange rates	199
Balance — June 30, 2017	615,451
North American OTC Healthcare
Goodwill [Roll Forward]
Balance — March 31, 2017	576,453
Adjustments	0
Effects of foreign currency exchange rates	0
Balance — June 30, 2017	576,453
International OTC Healthcare
Goodwill [Roll Forward]
Balance — March 31, 2017	32,554
Adjustments	0
Effects of foreign currency exchange rates	199
Balance — June 30, 2017	32,753
Household Cleaning
Goodwill [Roll Forward]
Balance — March 31, 2017	6,245
Adjustments	0
Effects of foreign currency exchange rates	0
Balance — June 30, 2017	$ 6,245

Goodwill (Narrative) (Details)

Goodwill (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Jun. 30, 2017	Jan. 26, 2017
Goodwill [Line Items]
Goodwill	$ 615,252	$ 615,451
Goodwill impairment	$ 0
C.B. Fleet Company, Inc.
Goodwill [Line Items]
Goodwill			$ 268,577

Intangible Assets, net (Schedul

Intangible Assets, net (Schedule of Reconciliation of Activity Affecting Intangible Assets) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Mar. 31, 2017
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	$ 2,589,155
Indefinite Lived Trademarks, ending balance	2,589,615
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite Lived Trademarks and Customer Relationships, accumulated amortization, beginning balance	127,343
Accumulated amortization, additions	5,854
Accumulated amortization, effects of foreign exchange rates	6
Finite Lived Trademarks and Customer Relationships, accumulated amortization, ending balance	133,203
Intangible Assets, Gross [Abstract]
Totals, gross, beginning balance	3,030,956
Totals, effects of foreign currency exchange rate	520
Totals, gross, ending balance	3,031,476
Finite-Lived Intangible Assets, Net [Abstract]
Finite-lived, net	308,658	$ 314,458
Intangible Assets, Net [Abstract]
Intangible assets, net	2,898,273	$ 2,903,613
Finite Lived Trademarks and Customer Relationships
Finite-Lived Intangible Assets, Gross [Abstract]
Finite Lived Trademarks and Customer Relationships, beginning balance	441,801
Finite Lived Trademarks and Customer Relationships, effects of foreign currency exchange rate	60
Finite Lived Trademarks and Customer Relationships, ending balance	441,861
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite Lived Trademarks and Customer Relationships, accumulated amortization, beginning balance	127,343
Accumulated amortization, additions	5,854
Accumulated amortization, effects of foreign exchange rates	6
Finite Lived Trademarks and Customer Relationships, accumulated amortization, ending balance	133,203
Finite-Lived Intangible Assets, Net [Abstract]
Finite-lived, net	308,658
Indefinite Lived Trademarks
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	2,589,155
Indefinite Lived Trademarks, effects of foreign currency exchange rate	460
Indefinite Lived Trademarks, ending balance	$ 2,589,615

Intangible Assets, net (Narrati

Intangible Assets, net (Narrative) (Details) $ in Thousands	Jan. 26, 2017USD ($)
C.B. Fleet Company, Inc.
Finite-Lived Intangible Assets [Line Items]
Intangible assets, net	$ 747,600

Other Accrued Liabilities (Summ

Other Accrued Liabilities (Summary of Accrued Liabilities and Accounts Payable) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017
Payables and Accruals [Abstract]
Accrued marketing costs	$ 35,284	$ 29,384
Accrued compensation costs	8,973	15,535
Accrued broker commissions	1,096	1,782
Income taxes payable	38	3,840
Accrued professional fees	2,168	2,412
Deferred rent	482	492
Accrued production costs	6,883	4,580
Accrued lease termination costs	730	843
Income tax related payable	19,000	19,000
Other accrued liabilities	7,811	5,793
Total other accrued liabilities	$ 82,465	$ 83,661

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details)	Jun. 30, 2017USD ($)
2012 ABL Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, amount outstanding	$ 90,000,000
Line of credit facility, remaining borrowing capacity	$ 77,400,000
Senior Notes | 2016 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	6.375%
Senior Notes | 2013 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	5.375%

Long-Term Debt (Schedule of Lon

Long-Term Debt (Schedule of Long-term Debt) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Mar. 31, 2017
Debt Instrument [Line Items]
Long-term debt, gross	$ 2,172,000	$ 2,222,000
Current portion of long-term debt	0	0
Long-term debt	2,172,000	2,222,000
Less unamortized debt costs	(26,591)	(28,268)
Long-term debt, net	2,145,409	2,193,732
2012 ABL Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term debt, gross	$ 90,000	90,000
Senior Notes | 2016 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	6.375%
Long-term debt, gross	$ 350,000	350,000
Senior Notes | 2013 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	5.375%
Long-term debt, gross	$ 400,000	400,000
Term B-4 Loans | 2012 Senior Notes
Debt Instrument [Line Items]
Long-term debt, gross	$ 1,332,000	$ 1,382,000
Term B-4 Loans | 2012 Senior Notes | Base Rate
Debt Instrument [Line Items]
Debt instrument, margin step-down	2.50%
Term B-4 Loans | 2012 Senior Notes | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate (percent)	2.75%
Debt Instrument, variable rate, minimum	0.75%

Long-Term Debt (Maturities of L

Long-Term Debt (Maturities of Long-term Debt) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017
Debt Disclosure [Abstract]
2018 (remaining nine months ending March 31, 2018)	$ 0
2,018	0
2,019	0
2,020	0
2,021	490,000
Thereafter	1,682,000
Long-term debt, gross	$ 2,172,000	$ 2,222,000

Fair Value Measurements (Summar

Fair Value Measurements (Summary of Carrying Amounts and Estimated Fair Values) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017
Senior Notes | 2016 Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	$ 350,000	$ 350,000
Senior Notes | 2013 Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	400,000	400,000
Term Loans | Term B-4 Loans | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	1,332,000	1,382,000
Revolving Credit Facility | 2012 ABL Revolver | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
2012 ABL Revolver	90,000	90,000
Fair Value, Measurements, Recurring | Senior Notes | 2016 Senior Notes | Fair Value | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	373,188	367,500
Fair Value, Measurements, Recurring | Senior Notes | 2013 Senior Notes | Fair Value | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	412,500	409,000
Fair Value, Measurements, Recurring | Term Loans | Term B-4 Loans | Fair Value | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	1,336,995	1,395,820
Fair Value, Measurements, Recurring | Revolving Credit Facility | 2012 ABL Revolver | Fair Value | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
2012 ABL Revolver	$ 90,000	$ 90,000

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details)	3 Months Ended
	Jun. 30, 2017USD ($)vote$ / sharesshares	Jun. 30, 2016$ / sharesshares	Mar. 31, 2017$ / sharesshares
Class of Stock [Line Items]
Common stock, shares authorized (in shares) | shares	250,000,000		250,000,000
Common stock, par value (in USD per share) | $ / shares	$ 0.01		$ 0.01
Preferred stock, shares authorized (in shares) | shares	5,000,000		5,000,000
Preferred stock, par value (in USD per share) | $ / shares	$ 0.01		$ 0.01
Voting rights, number of votes per common share owned | vote	1
Dividends declared on common stock | $	$ 0
Restricted Shares
Class of Stock [Line Items]
Restricted stock repurchased during period (in shares) | shares	19,616	24,988
Restricted stock acquired, average cost per share (in USD per share) | $ / shares	$ 52.36	$ 55.82

Accumulated Other Comprehensi57

Accumulated Other Comprehensive Loss (Components of AOCI) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2017	Mar. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]
Components of Accumulated Other Comprehensive Loss	$ 858,547	$ 822,549
Reclassification from accumulated other comprehensive loss into earnings	0	0
Cumulative translation adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Components of Accumulated Other Comprehensive Loss	(24,981)	(26,100)
Unrecognized net loss on pension plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Components of Accumulated Other Comprehensive Loss	(251)	(252)
Accumulated other comprehensive loss, net of tax
Accumulated Other Comprehensive Income (Loss) [Line Items]
Components of Accumulated Other Comprehensive Loss	$ (25,232)	$ (26,352)

Earnings Per Share (Computation

Earnings Per Share (Computation of Basis and Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Numerator
Net income (loss)	$ 33,759	$ (5,531)
Denominator
Denominator for basic earnings per share — weighted average shares outstanding (in shares)	53,038	52,881
Dilutive effect of unvested restricted stock units and options issued to employees and directors (in shares)	471	0
Denominator for diluted earnings per share (in shares)	53,509	52,881
Earnings per Common Share:
Basic net earnings per share (in USD per share)	$ 0.64	$ (0.10)
Diluted net earnings per share (in USD per share)	$ 0.63	$ (0.10)

Earnings Per Share (Antidilutiv

Earnings Per Share (Antidilutive Securities) (Details) - shares shares in Millions	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Outstanding Stock Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0.4	0.7

Share-Based Compensation (Narra

Share-Based Compensation (Narrative) (Details) $ / shares in Units, $ in Thousands	May 08, 2017$ / sharesshares	May 31, 2014shares	Jun. 30, 2014shares	Jun. 30, 2017USD ($)shares$ / shares	Jun. 30, 2016USD ($)$ / sharesshares
Share-based Compensation, Aggregate Disclosures:
Maximum number of shares per participant, 12 month period (in shares)		1,000,000	2,500,000
Extension of plan term			10 years
Share-based compensation costs charged against income | $				$ 1,700	$ 1,900
Tax benefit recognized from share-based compensation expense | $				500	700
Unrecognized compensation costs related to nonvested awards | $				$ 12,800
Unrecognized compensation costs related to nonvested awards, weighted average period for recognition				12 months
Total fair value of vested shares | $				$ 4,900	7,000
Proceeds from exercise of stock options | $				433	3,405
Tax benefit realized from exercise of stock options | $				$ 900	$ 1,400
Shares available for issuance under the Plan (in shares)				2,200,000
Stock options granted (in shares)				182,800	224,800
Options, Additional Disclosures:
Options granted, weighted-average grant-date fair value (in USD per share) | $ / shares				$ 21.20	$ 22.26
Options exercised, aggregate intrinsic value | $				$ 300
Performance Shares
Share-based Compensation, Aggregate Disclosures:
Granted in period to each independent director (in shares)	35,593
Restricted Stock Units (RSUs)
Share-based Compensation, Aggregate Disclosures:
Granted in period to each independent director (in shares)	54,773			90,400	49,400
Restricted Shares
Granted, weighted-average grant-date fair value (in USD per share) | $ / shares				$ 56.11	$ 57.16
Stock Options
Share-based Compensation, Aggregate Disclosures:
Stock options granted (in shares)	182,823
Stock options granted, exercise price (in USD per share) | $ / shares	$ 56.11
Stock Options | Minimum
Restricted Shares
Award vesting period				3 years
Stock Options | Maximum
Restricted Shares
Award vesting period				5 years
Options, Additional Disclosures:
Award exercisability period, from date of grant				10 years
Employee | Restricted Stock Units (RSUs) | Minimum
Restricted Shares
Award vesting period				3 years
Employee | Restricted Stock Units (RSUs) | Maximum
Restricted Shares
Award vesting period				5 years
Director | Restricted Stock Units (RSUs)
Restricted Shares
Award vesting period				1 year
Number of common shares into which each RSU may be converted (in shares)				1
Period following director's term in which RSUs may be settled				6 months
Long-term Equity Incentive Plan, 2005
Share-based Compensation, Aggregate Disclosures:
Number of shares authorized for grant under 2005 Long-Term Equity Incentive Plan (in shares)				5,000,000
Number of additional shares authorized (in shares)			1,800,000
Cliff Vesting | Employee | Restricted Stock Units (RSUs)
Restricted Shares
Award vesting period				3 years

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - Restricted Stock Units (RSUs) - $ / shares	May 08, 2017	Jun. 30, 2017	Jun. 30, 2016
Shares
Outstanding, beginning of period (in shares)		350,100	467,800
Granted (in shares)	54,773	90,400	49,400
Vested and issued (in shares)		(50,800)	(75,600)
Forfeited (in shares)		(2,300)	(76,200)
Outstanding, end of period (in shares)		387,400	365,400
Vested, end of period (in shares)		63,700	70,200
Weighted- Average Grant-Date Fair Value
Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)		$ 39.29	$ 35.22
Granted, weighted-average grant-date fair value (in USD per share)		56.11	57.16
Vested and issued, weighted-average grant-date fair value (in USD per share)		34.28	31.36
Forfeited, weighted-average grant-date fair value (in USD per share)		50.06	39.93
Outstanding, end of period, weighted-average grant-date fair value (in USD per share)		43.81	38
Vested, end of period, weighted-average grant-date fair value (in USD per share)		$ 20.31	$ 14.89

Share-Based Compensation (Stock

Share-Based Compensation (Stock Option Valuation Assumptions) (Details) - Stock Options - USD ($)	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	35.20%	37.80%
Expected dividends	$ 0	$ 0
Expected term in years	6 years	6 years
Risk-free rate	2.20%	1.70%

Share-Based Compensation (Sto63

Share-Based Compensation (Stock Option Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Shares
Outstanding, beginning of period (in shares)	772,300	727,700
Granted (in shares)	182,800	224,800
Exercised (in shares)	(13,800)	(105,700)
Forfeited or expired (in shares)	(5,800)	(45,500)
Outstanding, end of period (in shares)	935,500	801,300
Exercisable, end of period (in shares)	527,300	386,400
Weighted- Average Exercise Price
Outstanding, beginning of period, weighted-average exercise price (in USD per share)	$ 37.70	$ 30.70
Granted, weighted-average exercise price (in USD per share)	56.11	57.18
Exercised, weighted-average exercise price (in USD per share)	31.35	32.20
Forfeited or expired, weighted-average exercise price (in USD per share)	32.64	37.34
Outstanding, end of period, weighted-average exercise price (in USD per share)	41.42	37.55
Exercisable, end of period, weighted-average exercise price (in USD per share)	$ 31.95	$ 25.20
Options, Additional Disclosures:
Outstanding, end of period, weighted-average remaining contractual term	7 years 7 months 30 days	8 years
Exercisable, end of period, weighted-average remaining contractual term	6 years 5 months 18 days	6 years 8 months 12 days
Outstanding, end of period, aggregate intrinsic value	$ 12,123	$ 14,700
Exercisable, end of period, aggregate intrinsic value	$ 11,305	$ 11,669

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Effective income tax rate (percent)	35.90%	37.90%
Uncertain tax liability	$ 3.7		$ 4.1

Employee Retirement Plans (Expe

Employee Retirement Plans (Expected Return on Plan Assets) (Details) - Pension Plan $ in Thousands	3 Months Ended
	Jun. 30, 2017USD ($)
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 629
Expected return on assets	(726)
Net periodic benefit cost (income)	$ (97)

Employee Retirement Plans (Narr

Employee Retirement Plans (Narrative) (Details) - Pension Plan $ in Thousands	3 Months Ended
	Jun. 30, 2017USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (income)	$ (97)
Expected return on plan assets	6.25%
Non-qualified Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions	$ 100
Expected employer contributions, 2018 fiscal year	300
Qualified Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions	0
Expected employer contributions, 2018 fiscal year	$ 0

Commitments and Contingencies67

Commitments and Contingencies (Long-term Supply Agreement) (Details) - Third-party Manufacturing $ in Thousands	Jun. 30, 2017USD ($)
Long-term Purchase Commitment [Line Items]
2018 (Remaining nine months ending March 31, 2018)	$ 4,257
2,019	9,082
2,020	9,859
2,021	9,300
2,022	9,300
Thereafter	2,300
Total purchase commitment	$ 44,098

Concentrations of Risk (Narrati

Concentrations of Risk (Narrative) (Details)	3 Months Ended
	Jun. 30, 2017manufacturercustomer	Jun. 30, 2016manufacturer
Concentration Risk [Line Items]
Number of third-party manufacturers	116	102
Sales | Product Concentration Risk | Top 5 Customers
Concentration Risk [Line Items]
Concentration risk, percentage	43.20%	42.30%
Sales | Customer Concentration Risk | Walmart and Walgreens
Concentration Risk [Line Items]
Number of customers exceeding concentration risk benchmark | customer	2
Sales | Customer Concentration Risk | Walmart
Concentration Risk [Line Items]
Concentration risk, percentage	25.50%	20.70%
Sales | Customer Concentration Risk | Walgreens
Concentration Risk [Line Items]
Concentration risk, percentage	9.10%	10.30%
Sales | Supplier Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	77.20%	79.70%
Number of third-party manufacturers with long-term contracts	48	55
Accounts Receivable | Customer Concentration Risk | Walmart
Concentration Risk [Line Items]
Concentration risk, percentage	26.10%
Accounts Receivable | Customer Concentration Risk | Walgreens
Concentration Risk [Line Items]
Concentration risk, percentage	7.90%

Business Segments (Information

Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Segment Reporting Information, Profit (Loss):
Total revenues	$ 256,573	$ 209,575
Cost of sales	113,097	87,984
Gross profit	143,476	121,591
Advertising and promotion	36,944	27,635
Contribution margin	106,532	93,956
Other operating expenses	27,503	81,742
Operating income	79,029	12,214
Other expense	26,341	21,127
Income before income taxes	52,688	(8,913)
Provision (benefit) for income taxes	18,929	(3,382)
Net income (loss)	33,759	(5,531)
Pre-tax gain (loss) on sale	0	(55,453)
North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Total revenues	215,815	172,080
Cost of sales	86,501	64,234
Gross profit	129,314	107,846
Advertising and promotion	32,808	25,040
Contribution margin	96,506	82,806
International OTC Healthcare
Segment Reporting Information, Profit (Loss):
Total revenues	20,898	15,804
Cost of sales	9,950	6,948
Gross profit	10,948	8,856
Advertising and promotion	3,690	2,124
Contribution margin	7,258	6,732
Household Cleaning
Segment Reporting Information, Profit (Loss):
Total revenues	19,860	21,691
Cost of sales	16,646	16,802
Gross profit	3,214	4,889
Advertising and promotion	446	471
Contribution margin	2,768	4,418
Intersegment Eliminations | North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Total revenues	$ (1,429)	(1,221)
Disposal group, held-for-sale, not discontinued operations | Pediacare, New Skin and Fiber Choice | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Pre-tax gain (loss) on sale		$ (55,500)

Business Segments (Revenue by P

Business Segments (Revenue by Product) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	$ 256,573	$ 209,575
Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	29,799	28,653
Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	22,023	22,359
Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	66,739	33,823
Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	36,163	23,362
Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	28,326	28,803
Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	24,632	23,369
Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	27,784	26,028
Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	1,247	1,487
Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	19,860	21,691
North American OTC Healthcare
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	215,815	172,080
North American OTC Healthcare | Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	29,290	28,126
North American OTC Healthcare | Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	17,410	17,967
North American OTC Healthcare | Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	63,145	32,887
North American OTC Healthcare | Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	30,430	19,106
North American OTC Healthcare | Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	25,271	26,007
North American OTC Healthcare | Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	24,131	22,698
North American OTC Healthcare | Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	24,892	23,811
North American OTC Healthcare | Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	1,246	1,478
International OTC Healthcare
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	20,898	15,804
International OTC Healthcare | Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	509	527
International OTC Healthcare | Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	4,613	4,392
International OTC Healthcare | Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	3,594	936
International OTC Healthcare | Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	5,733	4,256
International OTC Healthcare | Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	3,055	2,796
International OTC Healthcare | Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	501	671
International OTC Healthcare | Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	2,892	2,217
International OTC Healthcare | Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	1	9
Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	19,860	21,691
Household Cleaning | Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Household Cleaning | Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Household Cleaning | Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Household Cleaning | Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Household Cleaning | Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Household Cleaning | Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Household Cleaning | Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Household Cleaning | Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Household Cleaning | Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	$ 19,860	$ 21,691

Business Segments (Assets by Se

Business Segments (Assets by Segment) (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Mar. 31, 2017
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	$ 615,451		$ 615,252
Indefinite-lived	2,589,615		2,589,155
Finite-lived, net	308,658		314,458
Intangible assets, net	2,898,273		2,903,613
Intangible assets, net (including goodwill)	3,513,724		3,518,865
Finite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Finite-lived, net	308,658
Indefinite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Indefinite-lived	2,589,615		2,589,155
North American OTC Healthcare
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	576,453		576,453
Intangible assets, net	2,686,120		2,691,392
Intangible assets, net (including goodwill)	3,262,573		3,267,845
North American OTC Healthcare | Finite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Finite-lived, net	281,784		287,056
North American OTC Healthcare | Indefinite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Indefinite-lived	2,404,336		2,404,336
International OTC Healthcare
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	32,753		32,554
Intangible assets, net	90,394		90,026
Intangible assets, net (including goodwill)	123,147		122,580
International OTC Healthcare | Finite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Finite-lived, net	6,376		6,468
International OTC Healthcare | Indefinite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Indefinite-lived	84,018		83,558
Household Cleaning
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	6,245		6,245
Intangible assets, net	121,759		122,195
Intangible assets, net (including goodwill)	128,004		128,440
Household Cleaning | Finite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Finite-lived, net	20,498		20,934
Household Cleaning | Indefinite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Indefinite-lived	$ 101,261		$ 101,261
Sales | UNITED STATES | Geographic concentration risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	87.70%	87.50%
Sales | CANADA | Geographic concentration risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	3.80%	4.70%
Sales | AUSTRALIA | Geographic concentration risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	4.10%	5.00%
Goodwill and Intangible Assets | UNITED STATES | Geographic concentration risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	96.50%		96.50%
Goodwill and Intangible Assets | Australia, the United Kingdom and Singapore | Geographic concentration risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	3.50%		3.50%

Condensed Consolidating Finan72

Condensed Consolidating Financial Statements (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Equity in (income) loss of subsidiaries	$ 0	$ 0
Eliminations
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Equity in (income) loss of subsidiaries	$ (68,155)	15,921
Restatement adjustment | Overstatement of equity in earnings of subsidiaries
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Equity in (income) loss of subsidiaries		(44,600)
Restatement adjustment | Eliminations | Overstatement of equity in earnings of subsidiaries
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Equity in (income) loss of subsidiaries		$ (44,600)

Condensed Consolidating Finan73

Condensed Consolidating Financial Statements (Condensed Consolidating Statements of Income and Comprehensive Income) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Revenues
Net sales	$ 256,487	$ 208,770
Other revenues	86	805
Total revenues	256,573	209,575
Cost of Sales
Cost of sales excluding depreciation	111,757	87,984
Cost of sales depreciation	1,340	0
Cost of sales	113,097	87,984
Gross profit	143,476	121,591
Operating Expenses
Advertising and promotion	36,944	27,635
General and administrative	20,336	19,457
Depreciation and amortization	7,167	6,832
Loss on divestitures	0	55,453
Total operating expenses	64,447	109,377
Operating income	79,029	12,214
Other (income) expense
Interest income	(69)	(57)
Interest expense	26,410	21,184
Equity in (income) loss of subsidiaries	0	0
Total other expense	26,341	21,127
Income before income taxes	52,688	(8,913)
(Benefit) provision for income taxes	18,929	(3,382)
Net income (loss)	33,759	(5,531)
Comprehensive income (loss), net of tax:
Currency translation adjustments	1,119	(5,824)
Unrecognized net gain on pension plans	1	0
Total other comprehensive (loss) income	1,120	(5,824)
Comprehensive income (loss)	34,879	(11,355)
Reportable Legal Entities | Prestige Brands Holdings, Inc.
Revenues
Net sales	0	0
Other revenues	0	0
Total revenues	0	0
Cost of Sales
Cost of sales excluding depreciation	0
Cost of sales depreciation	0
Cost of sales	0	0
Gross profit	0	0
Operating Expenses
Advertising and promotion	0	0
General and administrative	1,186	1,937
Depreciation and amortization	813	920
Loss on divestitures		0
Total operating expenses	1,999	2,857
Operating income	(1,999)	(2,857)
Other (income) expense
Interest income	(11,886)	(11,967)
Interest expense	8,374	8,440
Equity in (income) loss of subsidiaries	(33,265)	5,738
Total other expense	(36,777)	2,211
Income before income taxes	34,778	(5,068)
(Benefit) provision for income taxes	1,019	463
Net income (loss)	33,759	(5,531)
Comprehensive income (loss), net of tax:
Currency translation adjustments	1,119	(5,824)
Unrecognized net gain on pension plans	1
Total other comprehensive (loss) income	1,120	(5,824)
Comprehensive income (loss)	34,879	(11,355)
Reportable Legal Entities | Prestige Brands, Inc., the issuer
Revenues
Net sales	26,683	27,959
Other revenues	63	75
Total revenues	26,746	28,034
Cost of Sales
Cost of sales excluding depreciation	11,021
Cost of sales depreciation	0
Cost of sales	11,021	12,086
Gross profit	15,725	15,948
Operating Expenses
Advertising and promotion	4,270	4,745
General and administrative	2,703	2,188
Depreciation and amortization	166	151
Loss on divestitures		0
Total operating expenses	7,139	7,084
Operating income	8,586	8,864
Other (income) expense
Interest income	(21,117)	(21,262)
Interest expense	26,408	21,174
Equity in (income) loss of subsidiaries	(31,754)	13,259
Total other expense	(26,463)	13,171
Income before income taxes	35,049	(4,307)
(Benefit) provision for income taxes	1,203	3,178
Net income (loss)	33,846	(7,485)
Comprehensive income (loss), net of tax:
Currency translation adjustments	1,119	(5,824)
Unrecognized net gain on pension plans	1
Total other comprehensive (loss) income	1,120	(5,824)
Comprehensive income (loss)	34,966	(13,309)
Reportable Legal Entities | Combined Subsidiary Guarantors
Revenues
Net sales	212,912	168,205
Other revenues	248	801
Total revenues	213,160	169,006
Cost of Sales
Cost of sales excluding depreciation	94,783
Cost of sales depreciation	1,340
Cost of sales	96,123	71,462
Gross profit	117,037	97,544
Operating Expenses
Advertising and promotion	29,029	20,804
General and administrative	14,421	14,314
Depreciation and amortization	5,945	5,633
Loss on divestitures		55,453
Total operating expenses	49,395	96,204
Operating income	67,642	1,340
Other (income) expense
Interest income	(1,385)	(1,274)
Interest expense	25,560	24,901
Equity in (income) loss of subsidiaries	(3,136)	(3,076)
Total other expense	21,039	20,551
Income before income taxes	46,603	(19,211)
(Benefit) provision for income taxes	15,865	(7,912)
Net income (loss)	30,738	(11,299)
Comprehensive income (loss), net of tax:
Currency translation adjustments	1,119	(5,824)
Unrecognized net gain on pension plans	1
Total other comprehensive (loss) income	1,120	(5,824)
Comprehensive income (loss)	31,858	(17,123)
Reportable Legal Entities | Combined Non-Guarantor Subsidiaries
Revenues
Net sales	18,321	13,826
Other revenues	517	486
Total revenues	18,838	14,312
Cost of Sales
Cost of sales excluding depreciation	8,559
Cost of sales depreciation	0
Cost of sales	8,559	6,000
Gross profit	10,279	8,312
Operating Expenses
Advertising and promotion	3,645	2,086
General and administrative	2,026	1,018
Depreciation and amortization	243	128
Loss on divestitures		0
Total operating expenses	5,914	3,232
Operating income	4,365	5,080
Other (income) expense
Interest income	(998)	(159)
Interest expense	1,385	1,274
Equity in (income) loss of subsidiaries	0	0
Total other expense	387	1,115
Income before income taxes	3,978	3,965
(Benefit) provision for income taxes	842	889
Net income (loss)	3,136	3,076
Comprehensive income (loss), net of tax:
Currency translation adjustments	1,119	(5,824)
Unrecognized net gain on pension plans	0
Total other comprehensive (loss) income	1,119	(5,824)
Comprehensive income (loss)	4,255	(2,748)
Eliminations
Revenues
Net sales	(1,429)	(1,220)
Other revenues	(742)	(557)
Total revenues	(2,171)	(1,777)
Cost of Sales
Cost of sales excluding depreciation	(2,606)
Cost of sales depreciation	0
Cost of sales	(2,606)	(1,564)
Gross profit	435	(213)
Operating Expenses
Advertising and promotion	0	0
General and administrative	0	0
Depreciation and amortization	0	0
Loss on divestitures		0
Total operating expenses	0	0
Operating income	435	(213)
Other (income) expense
Interest income	35,317	34,605
Interest expense	(35,317)	(34,605)
Equity in (income) loss of subsidiaries	68,155	(15,921)
Total other expense	68,155	(15,921)
Income before income taxes	(67,720)	15,708
(Benefit) provision for income taxes	0	0
Net income (loss)	(67,720)	15,708
Comprehensive income (loss), net of tax:
Currency translation adjustments	(3,357)	17,472
Unrecognized net gain on pension plans	(2)
Total other comprehensive (loss) income	(3,359)	17,472
Comprehensive income (loss)	$ (71,079)	$ 33,180

Condensed Consolidating Finan74

Condensed Consolidating Financial Statements (Condensed Consolidating Balance Sheet) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2016	Mar. 31, 2016
Current assets
Cash and cash equivalents	$ 44,135	$ 41,855	$ 28,877	$ 27,230
Accounts receivable, net	134,725	136,742
Inventories	118,707	115,609
Prepaid expenses and other current assets	30,658	40,228
Total current assets	328,225	334,434
Property, plant and equipment, net	50,469	50,595
Goodwill	615,451	615,252
Intangible assets, net	2,898,273	2,903,613
Other long-term assets	7,143	7,454
Intercompany receivables	0	0
Investment in subsidiary	0	0
Total Assets	3,899,561	3,911,348
Current liabilities
Accounts payable	62,738	70,218
Accrued interest payable	8,414	8,130
Other accrued liabilities	82,465	83,661
Total current liabilities	153,617	162,009
Long-term debt
Principal amount	2,172,000	2,222,000
Less unamortized debt costs	(26,591)	(28,268)
Long-term debt, net	2,145,409	2,193,732
Deferred income tax liabilities	724,545	715,086
Other long-term liabilities	17,443	17,972
Intercompany payables	0	0
Total Liabilities	3,041,014	3,088,799
Stockholders' Equity
Common stock	533	533
Additional paid-in capital	460,401	458,255
Treasury stock, at cost	(7,621)	(6,594)
Accumulated other comprehensive (loss) income, net of tax	(25,232)	(26,352)
Retained earnings (accumulated deficit)	430,466	396,707
Total Stockholders' Equity	858,547	822,549
Total Liabilities and Stockholders' Equity	3,899,561	3,911,348
Prestige Brands Holdings, Inc.
Current assets
Cash and cash equivalents			5,311
Reportable Legal Entities | Prestige Brands Holdings, Inc.
Current assets
Cash and cash equivalents	6,176	6,168		4,440
Accounts receivable, net	0	0
Inventories	0	0
Prepaid expenses and other current assets	6,295	15,072
Total current assets	12,471	21,240
Property, plant and equipment, net	7,148	7,300
Goodwill	0	0
Intangible assets, net	0	0
Other long-term assets	2,500	2,500
Intercompany receivables	1,524,730	1,510,308
Investment in subsidiary	1,742,236	1,708,095
Total Assets	3,289,085	3,249,443
Current liabilities
Accounts payable	2,461	2,150
Accrued interest payable	0	0
Other accrued liabilities	8,076	12,905
Total current liabilities	10,537	15,055
Long-term debt
Principal amount	0	0
Less unamortized debt costs	0	0
Long-term debt, net	0	0
Deferred income tax liabilities	0	0
Other long-term liabilities	0	0
Intercompany payables	2,420,001	2,411,839
Total Liabilities	2,430,538	2,426,894
Stockholders' Equity
Common stock	533	533
Additional paid-in capital	460,401	458,255
Treasury stock, at cost	(7,621)	(6,594)
Accumulated other comprehensive (loss) income, net of tax	(25,232)	(26,352)
Retained earnings (accumulated deficit)	430,466	396,707
Total Stockholders' Equity	858,547	822,549
Total Liabilities and Stockholders' Equity	3,289,085	3,249,443
Reportable Legal Entities | Prestige Brands, Inc., the issuer
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	12,684	15,787
Inventories	16,399	16,484
Prepaid expenses and other current assets	848	245
Total current assets	29,931	32,516
Property, plant and equipment, net	407	439
Goodwill	66,007	66,007
Intangible assets, net	191,119	191,253
Other long-term assets	2,675	2,774
Intercompany receivables	2,434,924	2,477,928
Investment in subsidiary	2,430,790	2,397,916
Total Assets	5,155,853	5,168,833
Current liabilities
Accounts payable	11,247	14,576
Accrued interest payable	8,414	8,130
Other accrued liabilities	2,840	2,432
Total current liabilities	22,501	25,138
Long-term debt
Principal amount	2,172,000	2,222,000
Less unamortized debt costs	(26,591)	(28,268)
Long-term debt, net	2,145,409	2,193,732
Deferred income tax liabilities	58,206	55,945
Other long-term liabilities	0	0
Intercompany payables	1,261,252	1,260,499
Total Liabilities	3,487,368	3,535,314
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	1,280,947	1,280,947
Treasury stock, at cost	0	0
Accumulated other comprehensive (loss) income, net of tax	(25,232)	(26,352)
Retained earnings (accumulated deficit)	412,770	378,924
Total Stockholders' Equity	1,668,485	1,633,519
Total Liabilities and Stockholders' Equity	5,155,853	5,168,833
Reportable Legal Entities | Combined Subsidiary Guarantors
Current assets
Cash and cash equivalents	4,467	4,984	2,278	2,899
Accounts receivable, net	106,028	105,403
Inventories	92,857	89,255
Prepaid expenses and other current assets	21,921	23,444
Total current assets	225,273	223,086
Property, plant and equipment, net	42,354	42,260
Goodwill	516,691	516,691
Intangible assets, net	2,616,653	2,622,226
Other long-term assets	1,151	1,170
Intercompany receivables	2,020,627	1,832,286
Investment in subsidiary	281,433	276,933
Total Assets	5,704,182	5,514,652
Current liabilities
Accounts payable	45,194	49,025
Accrued interest payable	0	0
Other accrued liabilities	65,109	59,711
Total current liabilities	110,303	108,736
Long-term debt
Principal amount	0	0
Less unamortized debt costs	0	0
Long-term debt, net	0	0
Deferred income tax liabilities	666,158	659,132
Other long-term liabilities	17,382	17,920
Intercompany payables	2,402,936	2,253,319
Total Liabilities	3,196,779	3,039,107
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	2,183,644	2,183,644
Treasury stock, at cost	0	0
Accumulated other comprehensive (loss) income, net of tax	(25,232)	(26,352)
Retained earnings (accumulated deficit)	348,991	318,253
Total Stockholders' Equity	2,507,403	2,475,545
Total Liabilities and Stockholders' Equity	5,704,182	5,514,652
Reportable Legal Entities | Combined Non-Guarantor Subsidiaries
Current assets
Cash and cash equivalents	33,492	30,703	21,288	19,891
Accounts receivable, net	16,013	15,552
Inventories	9,979	10,833
Prepaid expenses and other current assets	1,594	1,467
Total current assets	61,078	58,555
Property, plant and equipment, net	560	596
Goodwill	32,753	32,554
Intangible assets, net	90,501	90,134
Other long-term assets	817	1,010
Intercompany receivables	195,602	193,609
Investment in subsidiary	0	0
Total Assets	381,311	376,458
Current liabilities
Accounts payable	3,836	4,467
Accrued interest payable	0	0
Other accrued liabilities	6,440	8,613
Total current liabilities	10,276	13,080
Long-term debt
Principal amount	0	0
Less unamortized debt costs	0	0
Long-term debt, net	0	0
Deferred income tax liabilities	181	9
Other long-term liabilities	61	52
Intercompany payables	91,694	88,474
Total Liabilities	102,212	101,615
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	269,234	269,234
Treasury stock, at cost	0	0
Accumulated other comprehensive (loss) income, net of tax	(24,980)	(26,100)
Retained earnings (accumulated deficit)	34,845	31,709
Total Stockholders' Equity	279,099	274,843
Total Liabilities and Stockholders' Equity	381,311	376,458
Eliminations
Current assets
Cash and cash equivalents	0	0	$ 0	$ 0
Accounts receivable, net	0	0
Inventories	(528)	(963)
Prepaid expenses and other current assets	0	0
Total current assets	(528)	(963)
Property, plant and equipment, net	0	0
Goodwill	0	0
Intangible assets, net	0	0
Other long-term assets	0	0
Intercompany receivables	(6,175,883)	(6,014,131)
Investment in subsidiary	(4,454,459)	(4,382,944)
Total Assets	(10,630,870)	(10,398,038)
Current liabilities
Accounts payable	0	0
Accrued interest payable	0	0
Other accrued liabilities	0	0
Total current liabilities	0	0
Long-term debt
Principal amount	0	0
Less unamortized debt costs	0	0
Long-term debt, net	0	0
Deferred income tax liabilities	0	0
Other long-term liabilities	0	0
Intercompany payables	(6,175,883)	(6,014,131)
Total Liabilities	(6,175,883)	(6,014,131)
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	(3,733,825)	(3,733,825)
Treasury stock, at cost	0	0
Accumulated other comprehensive (loss) income, net of tax	75,444	78,804
Retained earnings (accumulated deficit)	(796,606)	(728,886)
Total Stockholders' Equity	(4,454,987)	(4,383,907)
Total Liabilities and Stockholders' Equity	$ (10,630,870)	$ (10,398,038)

Condensed Consolidating Finan75

Condensed Consolidating Financial Statements (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Operating Activities
Net income (loss)	$ 33,759	$ (5,531)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	8,507	6,832
Loss on divestitures	0	55,453
Loss on disposals of property and equipment	490	0
Deferred income taxes	9,225	(9,660)
Amortization of debt origination costs	1,746	2,231
Excess tax benefits from share-based awards	302	550
Stock-based compensation costs	1,713	1,940
Equity in income of subsidiaries	0	0
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	1,543	5,151
Inventories	(2,899)	(4,327)
Prepaid expenses and other current assets	9,604	5,697
Accounts payable	(8,024)	(3,401)
Accrued liabilities	(1,558)	(3,634)
Noncurrent assets and liabilities	(287)	0
Net cash provided by operating activities	54,121	51,301
Investing Activities
Purchases of property, plant and equipment	(2,554)	(895)
Acquisition of Fleet escrow payment	970	0
Net cash used in investing activities	(1,584)	(895)
Financing Activities
Term loan repayments	(50,000)	(50,000)
Payments of debt origination costs	0	(9)
Proceeds from exercise of stock options	433	3,405
Fair value of shares surrendered as payment of tax withholding	(1,027)	(1,395)
Intercompany activity, net	0	0
Net cash used in financing activities	(50,594)	(47,999)
Effects of exchange rate changes on cash and cash equivalents	337	(760)
Increase in cash and cash equivalents	2,280	1,647
Cash and cash equivalents - beginning of period	41,855	27,230
Cash and cash equivalents - end of period	44,135	28,877
Prestige Brands Holdings, Inc.
Financing Activities
Cash and cash equivalents - end of period		5,311
Eliminations
Operating Activities
Net income (loss)	(67,720)	15,708
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	0	0
Loss on divestitures		0
Loss on disposals of property and equipment	0
Deferred income taxes	0	0
Amortization of debt origination costs	0	0
Excess tax benefits from share-based awards	0	0
Stock-based compensation costs	0	0
Equity in income of subsidiaries	68,155	(15,921)
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	0	0
Inventories	(435)	213
Prepaid expenses and other current assets	0	0
Accounts payable	0	0
Accrued liabilities	0	0
Noncurrent assets and liabilities	0
Net cash provided by operating activities	0	0
Investing Activities
Purchases of property, plant and equipment	0	0
Acquisition of Fleet escrow payment	0
Net cash used in investing activities	0	0
Financing Activities
Term loan repayments	0	0
Payments of debt origination costs		0
Proceeds from exercise of stock options	0	0
Fair value of shares surrendered as payment of tax withholding	0	0
Intercompany activity, net		0
Net cash used in financing activities	0	0
Effects of exchange rate changes on cash and cash equivalents	0	0
Increase in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	0	0
Reportable Legal Entities | Prestige Brands Holdings, Inc.
Operating Activities
Net income (loss)	33,759	(5,531)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	813	920
Loss on divestitures		0
Loss on disposals of property and equipment	0
Deferred income taxes	0	(9)
Amortization of debt origination costs	0	0
Excess tax benefits from share-based awards	302	550
Stock-based compensation costs	1,678	1,940
Equity in income of subsidiaries	(33,265)	5,738
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	0	0
Inventories	0	0
Prepaid expenses and other current assets	8,777	6,299
Accounts payable	271	(1,556)
Accrued liabilities	(4,674)	(4,294)
Noncurrent assets and liabilities	0
Net cash provided by operating activities	7,661	4,057
Investing Activities
Purchases of property, plant and equipment	(620)	(225)
Acquisition of Fleet escrow payment	0
Net cash used in investing activities	(620)	(225)
Financing Activities
Term loan repayments	0	0
Payments of debt origination costs		0
Proceeds from exercise of stock options	433	3,405
Fair value of shares surrendered as payment of tax withholding	(1,027)	(1,395)
Intercompany activity, net	(6,439)	(4,971)
Net cash used in financing activities	(7,033)	(2,961)
Effects of exchange rate changes on cash and cash equivalents	0	0
Increase in cash and cash equivalents	8	871
Cash and cash equivalents - beginning of period	6,168	4,440
Cash and cash equivalents - end of period	6,176
Reportable Legal Entities | Prestige Brands, Inc., the issuer
Operating Activities
Net income (loss)	33,846	(7,485)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	166	151
Loss on divestitures		0
Loss on disposals of property and equipment	0
Deferred income taxes	2,261	385
Amortization of debt origination costs	1,746	2,231
Excess tax benefits from share-based awards	0	0
Stock-based compensation costs	0	0
Equity in income of subsidiaries	(31,754)	13,259
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	2,133	1,858
Inventories	85	(606)
Prepaid expenses and other current assets	(603)	(281)
Accounts payable	(3,329)	(721)
Accrued liabilities	692	975
Noncurrent assets and liabilities	0
Net cash provided by operating activities	5,243	9,766
Investing Activities
Purchases of property, plant and equipment	0	(23)
Acquisition of Fleet escrow payment	970
Net cash used in investing activities	970	(23)
Financing Activities
Term loan repayments	(50,000)	(50,000)
Payments of debt origination costs		(9)
Proceeds from exercise of stock options	0	0
Fair value of shares surrendered as payment of tax withholding	0	0
Intercompany activity, net	43,787	40,266
Net cash used in financing activities	(6,213)	(9,743)
Effects of exchange rate changes on cash and cash equivalents	0	0
Increase in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	0	0
Reportable Legal Entities | Combined Subsidiary Guarantors
Operating Activities
Net income (loss)	30,738	(11,299)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	7,285	5,633
Loss on divestitures		55,453
Loss on disposals of property and equipment	490
Deferred income taxes	7,026	(10,089)
Amortization of debt origination costs	0	0
Excess tax benefits from share-based awards	0	0
Stock-based compensation costs	0	0
Equity in income of subsidiaries	(3,136)	(3,076)
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(625)	4,800
Inventories	(3,602)	(3,835)
Prepaid expenses and other current assets	1,523	(697)
Accounts payable	(4,250)	109
Accrued liabilities	4,930	261
Noncurrent assets and liabilities	(287)
Net cash provided by operating activities	40,092	37,260
Investing Activities
Purchases of property, plant and equipment	(1,890)	(596)
Acquisition of Fleet escrow payment
Net cash used in investing activities	(1,890)	(596)
Financing Activities
Term loan repayments	0	0
Payments of debt origination costs		0
Proceeds from exercise of stock options	0	0
Fair value of shares surrendered as payment of tax withholding	0	0
Intercompany activity, net	(38,719)	(37,285)
Net cash used in financing activities	(38,719)	(37,285)
Effects of exchange rate changes on cash and cash equivalents	0	0
Increase in cash and cash equivalents	(517)	(621)
Cash and cash equivalents - beginning of period	4,984	2,899
Cash and cash equivalents - end of period	4,467	2,278
Reportable Legal Entities | Combined Non-Guarantor Subsidiaries
Operating Activities
Net income (loss)	3,136	3,076
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	243	128
Loss on divestitures		0
Loss on disposals of property and equipment	0
Deferred income taxes	(62)	53
Amortization of debt origination costs	0	0
Excess tax benefits from share-based awards	0	0
Stock-based compensation costs	35	0
Equity in income of subsidiaries	0	0
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	35	(1,507)
Inventories	1,053	(99)
Prepaid expenses and other current assets	(93)	376
Accounts payable	(716)	(1,233)
Accrued liabilities	(2,506)	(576)
Noncurrent assets and liabilities	0
Net cash provided by operating activities	1,125	218
Investing Activities
Purchases of property, plant and equipment	(44)	(51)
Acquisition of Fleet escrow payment	0
Net cash used in investing activities	(44)	(51)
Financing Activities
Term loan repayments	0	0
Payments of debt origination costs		0
Proceeds from exercise of stock options	0	0
Fair value of shares surrendered as payment of tax withholding	0	0
Intercompany activity, net	1,371	1,990
Net cash used in financing activities	1,371	1,990
Effects of exchange rate changes on cash and cash equivalents	337	(760)
Increase in cash and cash equivalents	2,789	1,397
Cash and cash equivalents - beginning of period	30,703	19,891
Cash and cash equivalents - end of period	$ 33,492	$ 21,288

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details) - Restricted Stock Units (RSUs)	Aug. 01, 2017shares	May 08, 2017shares	Jun. 30, 2017shares	Jun. 30, 2016shares
Subsequent Event [Line Items]
Granted in period to each independent director (in shares)		54,773	90,400	49,400
Director
Subsequent Event [Line Items]
Number of common shares into which each RSU may be converted (in shares)			1
Period following director's term in which RSUs may be settled			6 months
Director | Subsequent Event [Member]
Subsequent Event [Line Items]
Granted in period to each independent director (in shares)	2,564
Number of common shares into which each RSU may be converted (in shares)	1
Period following director's term in which RSUs may be settled	6 months